The invention relates to N-bisaryl-and N-aryl-cycloalkylidenyl-α-sulfin- and α-sulfonamino acid amides of the general formula I including the optical isomers thereof and mixtures of such isomers, wherein n is a number zero or one; Ri is C1-C12alkyl ; C1-Cl2alkyl substituted with Ci-C4alkoxy, C1-C4alkylthio, C1-C4alkylsulfonyl, C3-Cgcycloalkyl, cyano, C1-C6alkoxycarbonyl, C3-C6alkenyloxycarbonyl or C3-C6alkynyloxy- carbonyl ; C2-C12alkenyl ; C2-Cl2alkynyl ; C1-C12haloalkyl ; or a group NR11Rt2 wherein R11 and R12 are each independently of the other Ci-C6alkyl, or together are tetra-or penta- methylene ; R2 and R3 are each independently hydrogen; Ci-Csalkyl ; C1-C8alkyl substituted with hydroxy, mercapto, Ci-C4alkoxy or C1-C4alkylthio ; C3-C8alkenyl ; C3-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycloalkyl-C1-C4alkyl; optionally substituted aryl ; optionally substituted heteroaryl ; or the two groups R2 and R3 together with the carbon atom to which they are bonded form a three-to eight-membered hydrocarbon ring; A is an optionally substituted saturated or unsaturated Cs-Cg-cydoafkytidene, optionally substituted phenylidene or optionally substituted saturated or unsaturated heterocyclylidene bridge, R4 and R5 are each independently hydrogen or an organic radical, and R6 is hydrogen; tri-C1-C4alkyl-silyl ; di-C1-C4alkyl-phenylsilyl ; Ci-C4alkyl-diphenylsilyf ; tri- phenytsijy) ; optionally substituted alkyl ; optionally substituted alkenyl or optionally substituted alkynyl.

In the above definition aryl includes aromatic hydrocarbon rings like phenyl, naphthyl, anthracenyl, phenanthrenyl, with phenyl being preferred.

Heteroaryl stands for aromatic ring systems comprising mono-, bi-or tricyclic systems being formed by 1 or 2 five-to six-membered condensed rings wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member. Typically heteroaryl comprises 1 to 4 identical or different heteroatoms selected from nitrogen, oxygen and sulfur, wherein the number of oxygen and sulfuratoms normally does not exceed one. Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotriazolyl, benzothia- zolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quinoxalinyl, quinazolinyl, cinno- linyl and naphthyridinyl.

The above aryl and heteroaryl groups may carry one or more identical or different substi- tuents. Normally not more than three substituents are present at the same time. Examples of substituents of aryl or heteroaryl groups are: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl- alkyl, phenyl and phenyl-alkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms; alkoxy ; alkenyloxy ; alkynyloxy ; alkoxyalkyl ; haloalkoxy, alkylthio ; haloalkylthio ; alkylsulfonyl ; formyl ; alkanol ; hydroxy; halogen ; cyano; nitro; amino; alkylamino ; dialkylamino ; carboxyl ; alkoxycarbonyl ; alkenyloxycarbonyl ; alkynyloxycarbonyl.

In the above definitions"halogen"or the prefix"halo"includes fluorine, chlorine, bromine and iodine.

The alkyl, alkenyl and alkynyl radicals may be straight-chain or branched. This applies also to the alkyl, alkenyl or alkynyl parts of other alkyl-, alkenyl-or alkynyl-containing groups.

The organic radical in R4 and R5 indicates that practically every substituent used in the art of organic chemistry may be placed in the indicated position at the phenylen bridge member.

Preferred are however the more frequently used radicals like C1-C8alkyl ; C2-C8alkenyl ; C2-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycloalkyl-C,-C4alkyl ; C1-C8alkylthio ; C1-C8alkylsulfonyl ; Ci-Cga ! koxy ; Cg-Cgatkenytoxy ; C3-C8alkynyloxy ; C3-C8cycloalkoxy ; C1-C8alkoxy-C1-C4alkyl ; C1-C8alkoxycarbonyl ; C3-C8alkenyloxycarbonyl ; C3-C8alkynyloxycarbonyl ; C1-C8alkanoyl ; C1-C8dialkylamino ; Ci-C8alkylamino ; wherein in each of the above radicals the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino.

Depending upon the number of carbon atoms mentioned, alkyl on its own or as part of another substituent is to be understood as being, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the isomers thereof, for example isopropyl, isobutyl, tert-butyl or sec-butyl, isopentyl or tert-pentyl.

Cycloalkyl is, depending upon the number of carbon atoms mentioned, cyclopropyl, cyclo- butyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.

Depending upon the number of carbon atoms mentioned, alkenyl as a group or as a struc- tural element of other groups is to be understood as being, for example, ethenyl, allyl, 1-propenyl, buten-2-yl, buten-3-yl, penten-1-yl, penten-3-yl, hexen-1-yl, 4-methyl-3-pentenyl or 4-methyl-3-hexenyl.

Alkynyl as a group or as a structural element of other groups is, for example, ethynyl, propyn-1-yl, propyn-2-yl, butyn-1-yl, butyn-2-yl, 1-methyl-2-butynyl, hexyn-1-yl, 1-ethyl-2- butynyl or octyn-1-yl.

A haloalkyl group may contain one or more (identical or different) halogen atoms, and for example may stand for CHCI2, CH2F, CCI3, CH2CI, CHF2, CF3, CH2CH2Br, C2CI5, C2F5, CH2Br, CHCIBr, CF3CH2, etc..

Where R2 and R3 together with the carbon atom to which they are attached form a hydrocarbon ring the ring corresponds to cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane or cyclooctane.

The bridge member A stands for a bivalent cyclic group (optionally substituted saturated or unsaturated C3-C8-cycloalkylidene, optionally substituted phenylidene or optionally substituted saturated or unsaturated heterocyclylidene) which comprises at least two carbon atoms as ring members which function as the linking ring members to the remainder of the molecule. The cyclic bivalent bridge bonded via two carbon atoms is either a hydrocarbon ring or a heterocyclic ring containing one to three heteroatoms selected from nitrogen, oxygen or sulfur, and which ring member may be of saturated, unsaturated or aromatic character, and may optionally carry one to three substituents being independently of each other selected from halogen, C1-C6alkyl, C,-C6alkoxy, Ct-C6haloalkyl, C1-C6alkoxy-carbonyl, nitro or cyano. Typical examples for the bivalent cyclic bridge are cyclopropylidene, cyclopentylidene, cyclopentenylidene, cyclohexylidene, cyclohexenylidene, cyclohex- adienylidene, bicyclohexylidene, cycloheptanylidene, bicycloheptylidene, norbonanylidene, norbonenylidene, phenylidene, naphthylidene, tetrahydrofuranylidene, tetrahydrothienyli- dene, pyrrolidinylidene, pyrazolidinylidene, triazolinylidene, thiazolidinylidene, isothiazolidi- nylidene, oxazolidinylidene, isoxazolidinylidene, piperidinylidene, piperazinylidene, morpho- linylidene, furanylidene, thienylidene, pyrrolylidene, pyrazolylidene, triazolylidene, thiazolyli- dene, oxazolylidene, isothiazolylidene, isoxazolylidene, oxadiazolylidene, thiadiazolylidene, pyridinylidene, triazinylidene or pyrimidinylidene.

Preferred members of this group are those wherein the two linking carbon atoms have vicinal positions in the cyclic bridge member. However, also remarkable fungicidal activity is associated with other carbon-bonded cyclic bridge members A.

Non-limiting examples of A are the following: C,-C, alkyl > >, ,,, 9<halogen/CH3/9<CI CH3/CI = ,,,,,, C,-C4alkyl /\/\ halogen CH3 CI CH CI 3 r r r e r I f r '-N -S N-S , I N'N^'^'N\ 'N\ C-C4alkyl' -Toy 1 IN N-0 N O N O < < halogen-CH,-CI-Ha N-N / NEZ N\\ NX N N'N- :/-' N- N-N ''--- ,- \/and N=N N N Preferred embodiments of the cyclic bridge A are the vicinally bonded ones: Even more preferred embodiments of the cyclic bridge A are: Within the definition of R6 the optionally substituted alkyl, optionally substituted alkenyl or optionally substituted alkynyl, encompass C1-C10alkyl ; C3-C10alkenyl ; C3-C10alkynyl ; C1-C10haloalkyl ; C3-C10haloalkenyl ; C3-C10haloalkynyl ; benzyl optionally substituted by Ci-Csalkyl, C2-C8alkenyl, C2-C8alkynyl, C3-CBcycloalkyl, <BR> <BR> C3-8cycloalkyl-C1-C4alkyl, C1-Caalkylthio, Ci-C8alkylsulfonyl, Ci-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkenyloxy-C1-C4alkyl, C1-Caalkynyloxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkyn- yloxycarbonyl, C1-C8alkanoyl, C1-C8dialkylamino, C1-C8alkylamino (wherein the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated) ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; a group-CR7R8-C-C-B wherein R7 and Ra are independently hydrogen or Ci-C4alkyl ; and B is either C3-C8cycloalkyl ; phenyl or phenyl substituted by C1-C8alkyl, C2-C8alkenyl, C2-C8al- kynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, Ci-C8alkylthio, C1-Csalkylsulfonyl, Cj-Csal- koxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C8-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8al- koxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, Ci-Cgalkanoyl, C1_Csdial- kylamino, C1-C8alkylamino (wherein the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated) ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; a group -CR7R8-CR9R10-X-B wherein R7, R8, Rg and Rio are independently hydrogen or C-C4alkyl ; X is -O-, -S- or -NR13- where R13 is hydrogen or Ct-C4alkyl ; and B is either C3-C8cycloalkyl ; phenyl or phenyl substituted by C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-Ci-C4alkyl, Ci-C8alkylthio, Ci-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkoxy- carbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-C8alkanoyl, C1-C8dialkyla- mino, C1-C8alkylamino (where all these alkyl, alkenyl, alkynyl or cycloalkyl containing groups may be partially or fully halogenated) ; carboxyl ; formyl ; halogen; nitro; cyano; hydroxy; or amino.

The presence of at least one asymmetric carbon atom and/or at least one asymmetric oxidized sulfur atom in the compounds of formula I means that the compounds may occur in optically isomeric forms. As a result of the presence of a possible aliphatic C=C double bond, geometric isomerism may also occur. Formula I is intended to include all those possible isomeric forms and mixtures thereof.

Preferred subgroups of compounds of formula I are those wherein n is one; or R, is C1-Cl2alkyl ; Cl-Cl2alkyl substituted with C1-C4alkoxy, C1-C4alkylthio or Ci-C4alkylsulfonyl ; C2-C12alkenyl ; C2-C12alkynyl ; C1-C12haloalkyl or a group NR11R12 wherein Ri, and R 2 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra-or penta-methylene ; or R1 is Ci-Cl2alkyl, C2-Cl2alkenyl ; C1-C12haloalkyl or a group NR11R12 wherein R11 and R12 are each independently of the other hydrogen or Ci-C6alkyl ; or Ri is C1-C4alkyl, C2-C4alkenyl ; C,-C4haloalkyl or Ci-C2dialkylamino ; or R1 is Ci-C4alkyl, vinyl ; C1-C4haloalkyl or dimethylamino ; or R2 is hydrogen and R3 is Ci-Cgatky) ; C1-C8alkyl substituted with hydroxy, C1-C4alkoxy, mercapto or Ci-C4alkylthio ; C3-C8alkenyl ; C3-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycloalkyl- C1-C4alkyl or is phenyl ; naphthyl or heteroaryl formed by 1 or 2 five-or six-membered rings containing 1 to 4 identical or different heteroatoms selected from oxygen nitrogen or sulfur, wherein each aromatic rings is optionally mono-or poly-substituted with C1-C8alkyl, C2-C8al- kenyl, C2-C8alkynyl, C3-Cscycloalkyl, C3-C8cycloalkyl-Ci_C6alkyl, Ci-C8alkoxy, C3. C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkyloxy, C1 Csalkylthio, Ci_C8alkylsulfonyl, Cl. C8alkanoyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-C8dialkylamino, Ci-Cgaikyiamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated or with halogen, nitro, cyano, hydroxy or amino; or R2 is hydrogen and R3 is Ci-C4alkyl ; C3-C4-alkenyl ; cyclopropyl or phenyl, naphthyl, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, pyridyl, pyrimidinyl, benzothienyl, benzthiazolyl, chinolinyl, pyrazolyl, indolyl, benzimidazolyl or pyrrolyl, wherein each of the aromatic rings is optionally-substituted with 1 to 3 substituents selected from Ci-C8alkyl, C2-C8alkenyl, C3-C8cycloalkyl, C1-C8alkoxy, C1-C8alkylthio, C1-C8alkoxycarbonyl, C1-C8haloalkyl, C1-C8haloalkoxy, C1-C8haloalkylthio, halogen, nitro or cyano; or R2 is hydrogen and R3 is C3-C4alkyl ; allyl ; cyclopropyl ; phenyl or phenyl substituted with 1 to 3 substituents selected from Ci-C8alkyl, C2-C8alkenyl, C3-C8cycloalkyl, C1 C8alkoxy, C1-C8alkylthio, C1-C8alkoxycarbonyl, C1-C8haloalkyl, C1-C8haloalkoxy, C1-C8haloalkylthio, halogen, nitro or cyano; or R2 is hydrogen and R3 is 2-propyl ; phenyl ; C1 4alkylphenyl or halophenyl ; or A is optionally substituted saturated or unsaturated carbocycle or heterocycle linked to the remainder of the molecule by vicinal ring member carbon atoms; or A is optionally substituted 1, 2-phenylene ; optionally substituted 2, 3-pyridinylidene ; optionally substituted 3, 4-pyridinylidene ; optionally substituted 2, 3-thiophenylidene ; optio- nally substituted 4, 5-thiazolinylidene ; optionally substituted 1, 2-cyclohexylidene ; optionally substituted 1, 2-cyclopentylidene ; optionally substituted 3, 4-tetrahydrofuranylidene or optio- nally substituted 1, 2-cyclopropylidene ; or A is 1, 2-phenylene ; 2, 3-pyridinylidene ; 3, 4-pyridinylidene or 2, 3-thiophenylidene ; each optionally substituted with halogen, C1-C6alkyl, C1-C6alkoxy, Ci-C6haloalkyl, C1-C6alkoxycar- bonyl, nitro or cyano; or is 1, 2-cyclohexylidene ; 1, 2-cyclopentylidene ; 3, 4-tetrahydrofuranyli- dene or 1, 2-cyclopropylidene, each optionally substituted with C1-C6-alkyl ; or A is 1, 2-phenylene ; 1, 2-cyclohexylidene or 1, 2-cyclopropylidene ; or R4 is hydrogen; Ci-C8alkyl ; C2-C8alkenyl ; C2-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cyc- loalkyl-Ci-C4alkyl ; C1-C8alkylthio ; Ci-C8alkylsulfonyl ; C1-C8alkoxy ; C3-C8alkenyloxy ; C3-C8al- kynyloxy ; C3-C8cycloalkoxy ; C1-C8alkoxy-Ci-C4alkyl ; C1-C8alkoxycarbonyl ; C3-C8alkenyloxy- carbonyl ; C3-C8alkynyloxycarbonyl ; Ci-C8alkanoyl ; Ci-C8dialkylamino or Ci-Cgatkytamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; or is carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; or R4 is hydrogen; Ci-C8alkyl ; C1-C8haloalkyl ; C2-C8alkenyl ; C2-C8alkynyl ; CI. C8alkylthio ; C1-C8haloalkylthio ; C1-C8alkoxy ; Ci-C8haloalkoxy ; C,-C8alkoxy-C1-C4alkyl ; Cl. C8alkoxycar- bonyl ; C1-C8alkanoyl ; formyl ; halogen ; nitro; cyano or hydroxy; or R4 is hydrogen; C1-C4alkyl ; C1-C4alkoxy ; Cy-C4haloalkoxy or halogen ; or R4 is hydrogen; methoxy or ethoxy; or R5 is hydrogen; C1-C8alkyl ; C2-C8alkenyl ; C2-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycioal- kyl-Ci-C4alkyl ; C1-C8alkylthio ; C1-C8alkylsulfonyl ; C1-C8alkoxy ; C3-C8alkenyloxy ; C3-C8alky- nyloxy ; C3-C8cycloalkoxy ; C1-C8alkoxy-C1-C4alkyl ; C1-C8alkoxycarbonyl ; C3-C8alkenyloxycar- bonyl ; C3-C8alkynyloxycarbonyi ; Ci-C8alkanoyl ; C1-C8dialkylamino or C1-C8alkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; or is carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; or R5 is hydrogen; C1-C4alkyl ; C1-C4haloalkyl ; C1-C4alkoxy ; C1-C4alkoxycarbonyl ; C1-C4al- kanoyl ; formyl ; halogen ; cyano or hydroxy; or R5 is hydrogen; C1-C4alkyl ; halogen or cyano; or R5 is hydrogen; or R6 is hydrogen; C1-C10alkyl ; C3-C10alkenyl ; C3-Cloalkynyl ; C1-C10haloalkyl ; C3. C10haloal- kenyl ; C3-C10haloalkynyl ; benzyl ; benzyl substituted with C1-C8alkyl, C2-C8alkenyl, C2-C8alky- nyl, C3-C8cycloalkyl, C3-8CYCLOALKYL-C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8al- koxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8al- kenyloxy-C1-C4alkyl, C1-C8alkynyloxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycar- bonyl, C3-C8alkynyloxycarbonyl, C1-C8alkanoyl, C1-C8dialkylamino, C1-C8alkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated, carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy; or amino; a group -CR7R8-C#C-B wherein R7 and R8 are independently hydrogen or C1-C4alkyl ; and B is either C3-C8cycloalkyl ; phenyl or phenyl substituted by C1-C8alkyl, C2-C8alkenyl, C2-C8al- kynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C,-C4alkyl, Ci-C8alkylthio, Ci-C8alkylsulfonyl, C1 C8al- koxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8al- koxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-C8alkanoyl, C1-C8dial- kylamino, C1-C8alkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; or a group -CR7R8-CR9R10-X-B wherein R7, R8, Rg and Rio are independently hydrogen or C1-C4alkyl ; X is-O-,-S-or-NR13-where R13 is hydrogen or C1-C4alkyl ; and B is either C3-C8cycloalkyl ; phenyl or phenyl substituted by C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkoxy- carbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-CBalkanoyl, C1-C8dialkyla- mino, C1-C8alkylamino, wherein in turnthe alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; or R6 is hydrogen; C1-C8alkyl ; C3-C8alkenyl ; C3-C8alkynyl ; C1-C6alkoxy-C1-C4alkyl ; C3-C6al- kenyloxy-C1-C4alkyl ; C3-C6alkynyloxy-C1-C4alkyl ; benzyl ; benzyl substituted with C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C1-C8alkylthio, C1-C8alkoxy, C1-C8haloalkyl, halogen, nitro or cyano; a group-CH2-C_C-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with C1-C8alkyl, C1-C8alkylthio, C,-C8alkoxy, C1-C8haloalkyl, halogen, nitro or cyano; or a group -CH2-CH2-O-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with C1-C8-alkyl, C1-C8-alkylthio, C1-C8-alkoxy, C1-C8-haloalkyl, halogen, nitro or cyano; or R6 is Ci-C6alkyl ; C3-C6alkenyl ; C3-C6alkynyl ; Ci-C6alkoxy-C,-C4alkyl ; C3-C6alkenyloxy- C1-C4alkyl ; C3-C6alkynyloxy-C1-C4alkyl ; benzyl ; benzyl substituted with Akyl ; C1-C8ha- loalkyl or halogen ; a group-CH2-C-C-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with by C1-C4alkyl or halogen, or a group-CH2-CH2-O-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with Ci-Csalkyl, halogen ; or R6 is Ci-C6alkyl ; C3-C6alkenyl ; C3-C6alkynyl ; C1-C6alkoxy-C1-C4alkyl ; C3-C6alkenyloxy- Ci-C4alkyl ; C3-C6alkynyloxy-C1-C4alkyl ; benzyl ; benzyl substituted with C1-C4alkyl, C1-C8halo- alkyl or halogen ; a group -CH2-C#C-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted withCl-C4alkyl or halogen ; or a group -CH2-CH2-O-B where B is either C3-C6cyc- loalkyl, phenyl or phenyl substituted with C1-C8alkyl or halogen.

Further preferred subgroups of the compounds of formula I are those wherein 1) n is zero or one; and R1 is C1-C12alkyl ; C1-C12alkyl substituted with C1-C4alkoxy, C1-C4alkylthio or C1-C4alkylsulfonyl ; C2-C12alkenyl ; C2-C12alkynyl ; C1-C12haloalkyl or a group NR11R12 wherein R11 and R12 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra-or penta-methylene ; and R2 is hydrogen and R3 is C1-C8alkyl ; C1-C8alkyl substituted with hydroxy, C1-C4alkoxy, mercapto or C1-C4alkylthio ; C3-C8alkenyl ; C3-C8alky- nyl ; C3-C8cycloalkyl ; C3-C8cycloalkyl-C1-C4alkyl or is phenyl ; naphthyl or heteroaryl formed by 1 or 2 five-or six-membered rings containing 1 to 4 identical or different heteroatoms selected from oxygen nitrogen or sulfur, wherein each aromatic rings is optonially mono-or poly-substituted with C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl- C1-C6alkyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkyloxy, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkanoyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alky- nyloxycarbonyl, Ci-C8dialkylamino, Ci-Cealkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated or with halogen, nitro, cyano, hydroxy or amino; and A is optionally substituted saturated or unsaturated carbocycle or heterocycle linked to the remainder of the molecule by vicinal ring member carbon atoms; and R4 is hydrogen; C1-C8alkyl ; C2-C8alkenyl ; C2-C8alkynyl ; C3-CBcycloalkyl ; C3-C8Cycloalkyl-C,-C4alkyl ; C1-C8alkylthio ; C1-C8alkylsulfonyl ; C1-C8alkoxy ; C3-C8alkenyloxy ; C3-C8alkynyloxy ; C3-C8cycloalkoxy ; C1-C8alkoxy-C1-C4alkyl ; C,-Csalkoxycarbonyl ; C3-C8alke- nyloxycarbonyl ; C3-C8alkynyloxycarbonyl ; C1-C8alkanoyl ; C1-C8dialkylamino or C1-C8al- kylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; or is carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; and R5 is hydrogen; C1-C8alkyl ; C2-C8alkenyl ; C2-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycloalkyl-C1-C4al- kyl ; C,-C8alkylthio ; C1-C8alkylsulfonyl ; C1-C8alkoxy ; C3-C8alkenyloxy ; C3-C8alkynyloxy ; C3-C8cycloalkoxy ; C1-C8alkoxy-C1-C4alkyl ; C1-C8alkoxycarbonyl ; C3-C8alkenyloxycarbonyl ; C3-C8alkynyloxycarbonyl ; C1-C8alkanoyl ; C1-C8dialkylamino or Ci-Csatkytamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; or is carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; and R6 is hydrogen; C1-C10alkyl ; C3-C10alkenyl ; C3-C10alkynyl ; Cl-Clohaloalkyl ; C3-C10haloalkenyl ; C3-C10haloalkynyl ; benzyl ; benzyl substituted with C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cyclo- alkyl-C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8al- kynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkenyloxy-C1-C4alkyl, C1-C8al- kynyloxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycar- bonyl, C1-C8alkanoyl, C1-C8dialkylamino, Ci-C8alkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated, carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy; or amino; a group-CR7R8-C_C-B wherein R7 and R8 are independently hydrogen or C1-C4alkyl ; and B is either C3-C8cycloalkyl ; phenyl or phenyl substituted by C1-C8alkyl, C2-Csalkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-Cscycloalkyl- C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, Cs-CecYcloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, Ci-C8alkanoyl, C1-CBdialkylamino, Ci-C8alkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; or a group-CR7R8-CRgRlo-X-B wherein R7, R8, R9 and Rio are independently hydrogen or C1-C4alkyl ; X is-O-,-S-or-NR13- where R13 is hydrogen or C1-C4alkyl ; and B is either C3-C8cycloalkyl ; phenyl or phenyl substituted by C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl- C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-Ci-C4alkyl, Cj-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-C8alkanoyl, C1-C8dialkylamino, C1-C8alkylamino, wherein in turn the alkyl, alkenyl, alkynyl or cycloalkyl moieties may be partially or fully halogenated ; carboxyl ; formyl ; halogen ; nitro; cyano; hydroxy or amino; or 2) n is one; and R1 is C1-C12alkyl, C2-C12alkenyl ; C-C12haloalkyl or a group NR11R12 wherein Rn and R12 are each independently of the other hydrogen or C1-C6alkyl ; and R2 is hydrogen and R3 is C1-C4alkyl ; C3-C4-alkenyl ; cyclopropyl or phenyl, naphthyl, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, pyridyl, pyrimidinyl, benzothienyl, benzthiazolyl, chinolinyl, pyrazolyl, indolyl, benzimidazolyl or pyrrolyl, wherein each of the aromatic rings is optionally substituted with 1 to 3 substituents selected from C1-C8alkyl, C2-C8alkenyl, C3-C8cycloalkyl, C1-C8alkoxy, C1-C8alkylthio, C1-C8alkoxycarbonyl, C1-C8haloalkyl, C1-C8haloalkoxy, C1-C8halo- alkylthio, halogen, nitro or cyano; and A is optionally substituted 1, 2-phenylene ; optionally substituted 2, 3-pyridinylidene ; optionally substituted 3, 4-pyridinylidene ; optionally substituted 2, 3-thiophenylidene ; optionally substituted 4, 5-thiazolinylidene ; optionally substituted 1, 2-cyclohexylidene ; optionally substituted 1, 2-cyclopentylidene ; optionally substituted 3, 4-tetrahydrofuranylidene or optio-nally substituted 1, 2-cyclopropylidene ; and R4 is hydrogen; Cl-Csalkyl ; C1-C8haloalkyl ; C2-C8alkenyl ; C2-C8alkynyl ; Ci. CBalkylthio ; C1-C8haloalkylthio ; C,-C8alkoxy ; C1-C8haloalkoxy ; C1-C8alkoxy-C1-C4alkyl ; C1-C8alkoxycar- bonyl ; C1-C8alkanoyl ; formyl ; halogen ; nitro; cyano or hydroxy; and R5 is hydrogen; C1-C4al- kyl ; C1-C4haloalkyl ; C1-C4alkoxy ; C1-C4alkoxycarbonyl ; Cl. C4alkanoyl ; formyl ; halogen ; cyano or hydroxy; and R6 is hydrogen; Cl-Caalkyl ; C3-Caalkenyl ; C3-C8alkynyl ; C1-C6alkoxy-C1-C4al- kyl ; C3. C6alkenyloxy-C1-C4alkyl ; C3-C6alkynyloxy-C1-C4alkyl ; benzyl ; benzyl substituted with C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C1-C8alkylthio, C1-C8alkoxy, C1-C8haloalkyl, halogen, nitro or cyano; a group-CH2-C-C-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with C1-C8alkyl, C1-C8alkylthio, C1-C8alkoxy, C1-C8haloalkyl, halogen, nitro or cyano; or a group-CH2-CH2-O-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with C1-C8-alkyl, C,-C8-alkylthio, C1-C8-alkoxy, C1-C8-haloalkyl, halogen, nitro or cyano; or 3) n is one; and R1 is C1-C4alkyl, C2-C4alkenyl ; C1-C4haloalkyl or C1-C2dialkylamino ; and R2 is hydrogen and R3 is C3-C4alkyl ; allyl ; cyclopropyl ; phenyl or phenyl substituted with 1 to 3 substituents selected from C1-C8alkyl, C2-C8alkenyl, C3-C8cycloalkyl, C1-C8alkoxy, C1-C8al- kylthio, C1-C8alkoxycarbonyl, C1-C8haloalkyl, C1-C8haloalkoxy, C1-C8haloalkylthio, halogen, nitro or cyano; and A is 1, 2-phenylene ; 2, 3-pyridinylidene ; 3, 4-pyridinylidene or 2,3-thiophe- nylidene ; each optionally substituted with halogen, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl, C1-C6alkoxycarbonyl, nitro or cyano; or is 1, 2-cyclohexylidene ; 1, 2-cyclopentylidene ; 3,4-te- trahydrofuranylidene or 1, 2-cyclopropylidene, each optionally substituted with Ci-C6-alkyl ; and R4 is hydrogen; C1-C4alkyl ; C1-C4alkoxy ; C,-C4haloalkoxy or halogen ; and R5 is hydrogen; C1-C4alkyl ; halogen or cyano; and R6 is C1-C6alkyl ; C3-C6alkenyl ; C3-C6alkynyl ; C1-C6alkoxy-C1-C4alkyl ; C3-C6alkenyloxy-C,-C4alkyl ; C3-C6alkynyloxy-C1-C4alkyl ; benzyl ; benzyl substituted with Ci-C4alkyl ; Ci. C, 3haloalkyl or halogen ; a group -CH2-C#C-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with by Ci-C4alkyl or halogen, or a group-CH2-CH2-O-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with C1-C8alkyl, halogen ; or 4) n is one; and R, is C1-C4alkyl, vinyl ; C1-C4haloalkyl or dimethylamino ; and R2 is hydrogen and R3 is 2-propyl ; phenyl ; C1 4alkylphenyl or halophenyl ; and A is 1, 2-phenylene ; 1, 2-cyclohexylidene or 1, 2-cyclopropylidene ; and R4 is hydrogen; methoxy or ethoxy; and R5 is hydrogen; and R6 is Ci-C6alkyl ; C3-C6alkenyl ; C3-C6alkynyl ; C1-C6alkoxy-C1-C4alkyl ; C3-C6alkenyloxy-C1-C4alkyl ; C3-C6alkynyloxy-C,-C4alkyl ; benzyl ; benzyl substituted with C1-C4alkyl, C1-C8haloalkyl or halogen ; a group-CH2-C-C-B where B is either C3-C6cycloal- kyl, phenyl or phenyl substituted with C1-C4alkyl or halogen ; or a group-CH2-CH2-O-B where B is either C3-C6cycloalkyl, phenyl or phenyl substituted with C1-C8alkyl or halogen.

Preferred individual compounds are: (2S)-2-ethanesulfonylamino-N-(3'-methoxy-4'-prop-2-ynyloxy-b iphenyl-2-yl)-3-methyl- butyramide, (2S)-2-methanesulfonylamino-N-(3'-methoxy-4'-prop-2-ynyloxy- biphenyl-2-yl)-3-methyl- butyramide, (2S)-2-{[(dimethylamino)-sulfonyl]-amino}-N-(3'-methoxy-4'-p rop-2-ynyloxy-biphenyl-2-yl)-3- methyl-butyramide, (2S)-N-(3',4'-dimethoxy-biphenyl-2-yl)-2-methanesulfonylamin o-3-methyl-butyramide, (2S)-N- (3', 4'-dimethoxy-biphenyl-2-yl)-2-ethanesulfonylamino-3-methyl-b utyramide, (2S)-N-(3',4'-dimethoxy-biphenyl-2-yl)-2-{[(dimethylamino)-s ulfonyl]-amino}-3-methyl- butyramide, (2S)-2-methanesulfonylamino-N-(3'-methoxy-4'-pent-2-ynyloxy- biphenyl-2-yl)-3-methyl- butyramide, (2S)-2-ethanesulfonylamino-N- (3'-methoxy-4'-pent-2-ynyloxy-biphenyl-2-yl)-3-methyl- butyramide, (2S)-2-{[(dimethylamino)-sulfonyl]-amino}-N-(3'-methoxy-4'-p ent-2-ynyloxy-biphenyl-2-yl)-3- methyl-butyramide, <BR> <BR> <BR> <BR> (2S)-N- (4'-ethoxy-3'-methoxy-biphenyl-2-yl)-2-methanesulfonylamino- 3-methyl-butyramide,<BR> <BR> <BR> <BR> <BR> <BR> <BR> (2S)-2-ethanesulfonylamino-N- (4'-ethoxy-3'-methoxy-biphenyl-2-yl)-3-methyl-butyramide,< ;BR> <BR> <BR> <BR> <BR> <BR> (2S)-2-{[(dimethylamino)-sulfonyl]-amino}-N-(4'-ethoxy-3'-me thoxy-biphenyl-2-yl)-3-methyl- butyramide, <BR> <BR> <BR> <BR> (2S)-2-methanesulfonylamino-N- [trans-2- (3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]- 3-methyl-butyramide, <BR> <BR> <BR> <BR> (2S)-2-ethanesulfonylamino-N- [trans-2- (3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]-3-<BR> <BR> <BR> <BR> <BR> <BR> <BR> methyl-butyramide,<BR> <BR> <BR> <BR> <BR> <BR> (2S)-2-{[(dimethylamino)-sulfonyl]-amino}-N-[trans-2-(3-meth oxy-4-prop-2-ynyloxy-phenyl)-<BR> <BR> <BR> <BR> <BR> <BR> <BR> cyclohexyl]-3-methyl-butyramide,<BR> <BR> <BR> <BR> <BR> <BR> <BR> (2S)-2-methanesulfonylamino-N- [trans-2- (3-methoxy-4-pent-2-ynyloxy-phenyl)-cyclohexyl]- 3-methyl-butyramide, <BR> <BR> <BR> <BR> (2S)-2-ethanesulfonylamino-N- [trans-2- (3-methoxy-4-pent-2-ynyloxy-phenyl)-cyclohexyl]-3- methyl-butyramide, and (2S)-2-{[(dimethylamino)-sulfonyl]-amino}-N-[trans-2-(3-meth oxy-4-pent-2-ynyloxy-phenyl)- cyclohexyl]-3-methyl-butyramide.

Certain oc-sulfin-and a-sulfonamino acid derivatives with a distinct chemical structure have been proposed for controlling plant-destructive fungi (for example in WO 95/030651, WO 00/32568 and WO 00/32569). The action of those preparations is not, however, satisfactory in all aspects of agricultural needs. Surprisingly, with the compound structure of formula 1, new kinds of microbiocides having a high level of activity have been found.

The N-bisaryl-and N-aryl-cycloalkylidenyl-a-sulfin-and a-sulfonamino acid amides of formula I may be obtained according to one of the following processes: An amino acid of formula 11 or a carboxyl-activated derivative of an amino acid of formula 11 wherein RI, n, R2 and R3 are as defined for formula 1, is reacted with an amine of formula III wherein A, R4, R5 and R6, are as defined for formula 1, optionally in the presence of a base and optionally in the presence of a diluting agent.

Carboxyl-activated derivatives of the amino acid of formula 11 encompasses all compounds having an activated carboxyl group like an acid halide, such as an acid chloride or an acid fluoride, like symmetrical or mixed anhydrides, such as mixed anhydrides with O-alkylcar- bonates, like activated esters, such as p-nitrophenylesters or N-hydroxysuccinimidesters, as well as in situ produced activated forms of the amino acid of formula 11 by condensating agents, such as dicyclohexylcarbodiimide, carbonyidiimidazol, benzotriazol-1-yloxy-tris- (dimethylamino) phosphonium hexafluorophosphate, O-benzotriazol-1-yl N, N, N', N'-bis (pen- tamethylene) uronium hexafluorophosphate, O-benzotriazol-1-yl N, N, N', N'-bis (tetrame- thylene) uronium hexafluorophosphate, O-benzotriazol-1-yl N, N, N', N'-tetramethyluronium hexafluorophosphate or benzotriazol-1-yloxy-tripyrrolidinophosphonium hexafluorophos- phate. The mixed anhydrides of the amino acids of the formula 11 can be prepared by reaction of an amino acid of formula If with chloroformic acid esters like chloroformic acid alkylesters, such as ethyl chloroformate or isobutyl chloroformate, optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N, N-diisopropyl- ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine. The acid halide of the amino acid of formula il may be prepared by reaction of an amino acid of formula 11 with an inorganic halide, such as thionyl chloride or phosphorous pentachloride, or with organic halides, such as phosgene or oxalyl chloride.

The present reaction is preferably performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e. g. dichloromethane or tolu- ene; ketones e. g. acetone; esters e. g. ethyl acetate; amides e. g. N, N-dimethylformamide ; nitriles e. g. acetonitrile ; or ethers e. g. diethylether, tert-butyl-methylether, dioxane or tetrahy- drofuran or water. It is also possible to use mixtures of these solvents. The reaction is per- formed optionally in the presence of an organic or inorganic base like a tertiary amine, e. g. triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-mor- pholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from-80 to +150 °C, preferentially at temperatures ranging from-40 to +40 °C.

The compounds of formula I may also be prepared by reaction of an amino acid derivative of formula V wherein R2, R3, R4, R5 and R6 are as defined for formula 1, with a sulfonyl halide or a sulfinyl halide of formula IV wherein Ri and n are as defined for formula I and where X is halide, preferentially chlorine or bromine.

The reaction is preferably performed in an inert solvent like aromatic, non-aromatic or halo- genated hydrocarbons, such as chlorohydrocarbons e. g. dichloromethane or toluene ; keto- nes e. g. acetone; esters e. g. ethyl acetate; amides e. g. N, N-dimethylformamide ; nitriles e. g. acetonitrile ; or ethers e. g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofuran or water. It is also possible to use mixtures of these solvents. The reaction is performed optio- nally in the presence of an organic or inorganic base like a tertiary amine, e. g. triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at tempera- tures ranging from-80 to +150 °C, preferentially at temperatures ranging from-40 to +40°C.

The compounds of formula I may also be prepared by reaction of a phenol of formula I' where Ri, n, R2, R3, R4, and R5 are as defined for formula 1, with a compound of formula VI where R6 is as defined for formula I but is not hydrogen and where Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate.

The reaction is performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e. g. dichloromethane or toluene ; ketones e. g. acetone or 2-butanone; esters e. g. ethyl acetate; ethers e. g. diethylether, tert-butyl- methylether, dioxane or tetrahydrofuran, amides e. g. dimethylformamide, nitriles e. g. acetonitrile, alcohols e. g. methanol, ethanol, isopropanol, n-butanol or tert-butanol, sulf- oxides e. g. dimethylsulfoxide or water. It is also possible to use mixtures of these solvents.

The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-pipe- ridine or N-methyl-morpholine, like a metal hydroxide, a metal carbonate or a metal alk- oxide, preferentially an alkali hydroxide, an alkali carbonate or an alkali alkoxide, such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, sodium tert-butoxide or potassium tert-butoxide at temperatures ranging from-80 to +200 °C, preferentially at temperatures ranging from 0 to +120 °C. d) Two alternative methods are availble for the preparation of selected novel intermediates of formula 111. The intermediates so obtained have been developed especially for the synthesis of the novel active ingredients according to present invention. Thus these intermediates present another aspect of present invention d1) 4 Ra (VIT) Han stop A Rua ,/--° HO R5 (VIII) d2) R4 R4 d2) , T step B 02N Rs IX) NO2 step C Ra Ra zu O-Rr3 ow O-R6 step D N02 NH2 Rus ('") Step A: The compounds of formula ! H' wherein R4, R5 and R6 are as defined for formula I and A is optionally substituted phenylidene, here exemplified as 1, 4-phenylidene, may be prepared by palladium-catalyzed cross-coupling reaction of an aryl boronic acid derivative of formula VlIl wherein R4, Rs and R6 are as defined for formula 1, with an aryl halide of formula VII wherein X is a halogen, preferentially bromine or iodine under the conditions of the Suzuki coupling, according to known procedures (Y. Miura et al., Synthesis 1995,1419 ; M. Hird et al, Synlett 1999, 438).

Step B: A p-nitrostyrene of formula IX wherein R4, R5 and R6 are as defined for formula I is heated in a Diels-Alder reaction (M. B. Smith and J. March, Advanced Organic Chemistry, 5t ed., Wiley, 2001, p. 1062) together with 1, 3-butadiene to give a 4-nitro-5-aryl- cyclohexenyl derivative of formula X, wherein R4, R5 and R6 are as defined for formula 1, and the 4, 5-cyclohexenylidene stands for the element A, under conditions known per se (C. M. Nachtsheim and A. W. Frahm, Arch. Pharm. (Weinheim) 1989, 322, 187).

Step C: A 4-nitro-5-aryl-cyclohexenyl derivative of formula X, wherein R4, R5 and R6 are as defined for formula I is reduced to a 1-nitro-2-aryl-cyclohexyl derivative of formula XI, wherein R4, R5 and R6 are as defined for formula I and the 1, 2-cyclohexylidene stands for the element A. The reduction is preferably performed by catalytic hydrogenation in the presence of a metal catalyst like palladium on carbon or palladium hydroxide on carbon at pressures ranging from 1 to 100 bar, preferentially at pressures ranging from 1 to 50 bar; and temperatures ranging from 0 to +150 °C, preferentially at temperatures ranging from +20 to +100 °C.

Step D: A 1-nitro-2-aryl-cyclohexyl derivative of formula Xi, wherein R4, R5 and R6 are as defined for formula I is then further reduced to an 2-arylcyclohexylamine of formula)))", wherein R4, R5 and R6 are as defined for formula 1. The reduction is preferably performed in the presence of a reagent such as zinc, tin or iron, each of these metals together with a mineral acid like hydrochloric acid or sulfuric acid, indium together with ammonium chloride, hydrazine or hydrazine hydrate together with Raney-Nickel, sodium borohydride, lithium aluminum hydride or by catalytic hydrogenation in the presence of a catalyst such as platinum oxide at temperatures ranging from-80 to +200 °C, preferentially at temperatures ranging from-40 to +120 °C.

The compounds of formula I are oils or solids at room temperature and are distinguished by valuable microbiocidal properties. They can be used in the agricultural sector or related fields preventively and curatively in the control of plant-destructive microorganisms. The compounds of formula I according to the invention are distinguished at low rates of concen- tration not only by outstanding microbiocidal, especially fungicidal, activity but also by being especially well tolerated by plants.

Surprisingly, it has now been found that the compounds of formula I have for practical purposes a very advantageous biocidal spectrum in the control of phytopathogenic micro- organisms, especially fungi. They possess very advantageous curative and preventive properties and are used in the protection of numerous crop plants. With the compounds of formula I it is possible to inhibit or destroy phytopathogenic microorganisms that occur on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later also remain protected, for example, against phytopathogenic fungi.

The novel compounds of formula I prove to be effective against specific genera of the fungus class Fungi imperfecti (e. g. Cercospora), Basidiomycetes (e. g. Puccinia) and Ascomycetes (e. g. Erysiphe and Venturia) and especially against Oomycetes (e. g.

Plasmopara, Peronospora, Pythium and Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phytopathogenic fungi. The compounds of formula I can also be used as dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phytopathogenic fungi that occur in the soil.

The invention relates also to compositions comprising compounds of formula I as active ingredient, especially plant-protecting compositions, and to the use thereof in the agri- cultural sector or related fields.

In addition, the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances described herein. Also included is a method of treating plants which is distin- guished by the application of the novel compounds of formula I or of the novel compositions.

Target crops to be protected within the scope of this invention comprise, for example, the following species of plants : cereals (wheat, barley, rye, oats, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and black- berries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucurbi- taceae (marrows, cucumbers, melons) ; fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamon, camphor) and plants such as tobacco, nuts, coffee, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, and also ornamentals.

The compounds of formula I are normally used in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with other active ingredients. Those other active ingredients may be fertilisers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides or insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application- promoting adjuvants customarily employed in formulation technology.

The compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.

Mixing components which are particularly preferred are azoles such as azoles, such as azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, S-imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole ; pyrimidinyl carbinols, such as ancymidol, fenarimol, nuarimol ; 2-amino-pyrimidines, such as bupirimate, dimethirimol, ethirimol ; morpholines, such as dodemorph, fenpropidine, fenpropimorph, spiroxamine, tridemorph; anilinopyrimidines, such as cyprodinil, mepanipyrim, pyrimethanil ; pyrroles, such as fenpiclonil, fludioxonil ; phenylamides, such as benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl ; benzimidazoles, such as benomyl, carbendazim, debacarb, fuberidazole, thiabendazole ; dicarboximides, such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone, vinclozolin ; carboxamides, such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, thifluzamide ; guanidines, such as guazatine, dodine, iminoctadine; strobi- lurines, such as azoxystrobin, kresoxim-methyl, metominostrobin, SSF-129, CGA 279202 (trifloxystrobin), picoxystrobin; dithiocarbamates, such as ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram; N-halogenmethylthiophthalimides, such as captafol, captan, dichlofluanid, fluoromide, folpet, tolyfluanid ; Cu compounds, such as Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper, oxine-copper; nitrophenol derivatives, such as dinocap, nitrothal-isopropyl ; organo-P derivatives, such as edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazophos, tolclofos-methyl ; various, such as AC 382042, acibenzolar-S-methyl, anilazine, blasticidin-S, quinomethionat, chloroneb, chlorothalonil, cymoxanil, dichlone, diclomezine, dicloran, diethofencarb, dimethomorph, dithianon, etridiazole, famoxadone, fenamidone, fenhexamid, fentin, ferimzone, fluazinam, flusulfamide, fosetyl-aluminium, hymexazol, IKF- 916, iprovalicarb, kasugamycin, methasulfocarb, MON65500, pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, RH-7281, RPA 407213, pyraclostrobin (BAS 500F), sulfur, SYP-Z071, triazoxide, tricyclazole, triforine, validamycin.

Suitable carriers and surfactants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as e. g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilisers. Such carriers and additives are described, for example, in WO 95/30651.

A preferred method of applying a compound of formula 1, or an agrochemical composition comprising at least one of those compounds, is application to the foliage (foliar application), the frequency and the rate of application depending upon the risk of infestation by the pathogen in question. The compounds of formula I may also be applied to seed grains (coating) either by impregnating the grains with a liquid formulation of the active ingredient or by coating them with a solid formulation.

The compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e. g. into emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and by encapsulation in e. g. polymer substances. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended object- ives and the prevailing circumstances.

Advantageous rates of application are normally from 1 g to 2 kg of active ingredient (a. i.) per hectare (ha), preferably from 10 g to 1 kg a. i. /ha, especially from 25 g to 750 g a. i./ha.

When used as seed dressings, rates of from 0.001 g to 1.0 g of active ingredient per kg of seed are advantageously used.

The formulations, i. e. the compositions, preparations or mixtures comprising the com- pound (s) (active ingredient (s) ) of formula I and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e. g. by homogeneously mixing and/or grinding the active ingredient with extenders, e. g. solvents, solid carriers and, where appropriate, surface-active compounds (surfactants).

Further surfactants customarily used in formulation technology will be known to the person skilled in the art or can be found in the relevant technical literature.

The agrochemical compositions usually comprise 0.01 to 99 % by weight, preferably 0.1 to 95 % by weight, of a compound of formula 1, 99.99 to 1 % by weight, preferably 99.9 to 5 % by weight, of a solid or liquid adjuvant, and 0 to 25 % by weight, preferably 0.1 to 25 % by weight, of a surfactant.

Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.

The compositions may also comprise further ingredients, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as fertilisers or other active ingredients for obtaining special effects.

The Examples which follow illustrate the invention described above, without limiting the scope thereof in any way. Temperatures are given in degrees Celsius.

Preparation Examples for compounds of formula I : Example A1. 1: (S)-2-Ethanesulfonylamino-N-(3'-methoxy-4'-prop-2-ynyloxy-bi phenyl-2-vl)- 3-methyl-butyramide a) (4-Bromo-2-methoxy-phenoxy)-tert-butyl-diphenyi-silane 76.8 ml (300 mmol) tert-butyldiphenylchlorosilane are added to a solution of 40.61 g (200 mmol) 4-bromoguaiacol and 27.23 g (400 mmol) imidazole in 200 ml dichloromethane at 0°C, and the mixture is stirred for 4 hours at room temperature. The solution is diluted and extracted with 300 mi water. Flash-chromatography of the residue (ethyl acetate/hexane 3: 97) yields (4-bromo-2-methoxy-phenoxy)-tert-butyl-diphenyl-silane as a colorless oil.

1H-NMR (CDCI o 300 MHz): 1.15 (s, 9 H, t-Bu), 3.55 (s, 3 H, OMe), 6.55 (d, 1H, ar), 6.78 (2m, 1 H, ar), 6.66 (s, 1 H, ar), 7.3-7. 5 (m, 6H, ar), 7.65-7. 75 (m, 4H, ar). b) 4- (tert-Butyl-diphenyi-silanyloxy)-3-methoxy-phenyl-boronic acid At-78°C, 140 ml n-BuLi (1.6 M in hexane, 223.8 mmol) in 600 ml THF are added to a solu- tion of 89.92 g (203.4 mmol) (4-bromo-2-methoxy-phenoxy)-tert-butyl-diphenyl-silane over a period of 30 minutes. After further 30 minutes at-78°C, 140.9 ml (610.4 mmol) triisopropyl- borate are added over a period of 30 minutes. The mixture is allowed to warm up to room temperature and is hydrolyse at 0°C with a 10% HCI solution within 30 minutes. After separation of the water phase, the organic phase is dried over MgS04 and crystallized from ethyl acetate and a mixture of ethyl acetate/heptane. 4-(tert-Butyl-diphenyl-silanyloxy)-3- methoxy-phenyl-boronic acid is isolated as a light yellow solid (m. p. 193-196°C). c) 4'-(tert-Butyl-diphenyl-silanyloxy)-3'-methoxy-biphenyl-2-yl amine A solution of 17.89 g (44.0 mmol) 4-(tert-butyl-diphenyl-silanyloxy)-3-methoxy-phenyl-boro- nic acid, 6.89 g (31.45 mmol) 2-iodoaniline, 17.4 g (125.8 mmol) K2Co3 and 425 mg (6 mol%) Pd (OAc) 2 in 140 ml THF and 80 mi H20 is refluxed for 20 hours. After cooling the mixture is filtrated over cellite and concentrated. The residue is dissolved in ethyl acetate and washed with water. After drying (MgS04) and evaporating, the residue is subjected to flash-chromatography (ethyl acetate/hexane 1: 9). 4'-(tert-Butyl-diphenyl-silanyloxy)-3'-meth- oxy-biphenyl-2-ylamine is isolated as a colorless oil. 1H-NMR (CDCI, 300 MHz) : 1.15 (s, 9 H, t-Bu), 3.55 (s, 3 H, OMe), 6.6-6. 9 (m, 5H, ar), 7.05-7. 15 (m, 2H. ar), 7.30-7. 50 (m, 6H, ar), 7.75 (m, 4H, ar). d) (2S)-N-[4'-(tert-Butyl-diphenyl-silanyloxy)-3'-methoXv-biphe nVl-2-vl]-2-ethanesulfonyl-<BR> amino-3-methyl-butyramide A solution of 2.57 g (12.3 mmol) (2S)-2-ethanesulfonylamino-3-methyl-butyric acid, 1.0 ml (12.3 mmol) pyridine and 0.34 mi (4.1 mmol) cyanurfluoride (2,4, 6-trifluor-1, 3,5-triazine) in 20 ml dichloromethane is stirred for 3 hours at room temperature under a nitrogen atmos- phere. After aqueous extraction, the organic phase is dried over MgSO4 and evaporated.

The crude acide fluoride is dissolved in 10 ml dichloromethane and 4.64 g (10.23 mmol) 4'-(tert-butyl-diphenyl-silanyloxy)-3'-methoxy-biphenyl-2-yl amine as well as 2.31 g (11.25 mmol) 2, 6-di-tert-butyl-4-methyl-pyridine are added. The solution is stirred for 20 hours at room temperature under a nitrogen atmosphere. After usual work-up, the crude product is subjected to flash-chromatography (ethyl acetate/hexane 3; 7) yielding (2S)-N- [4'- (tert-butyl- <BR> <BR> <BR> <BR> diphenyl-silanyloxy)-3'-methoxy-biphenyl-2-yl]-2-ethanesulfo nylamino-3-methyl-butyramide as a yellow foam.'H-NMR (CDCIQ. 300 MHz): 0.8-1. 0 (dd, 6H, 2 Me), 1.15 (s, 9 H, t-Bu), 1.35 (t, 3H, Me), 1.9 (m, 1 H, CH), 2.90, (dd, 2H, CH2), 3.55 (m, 1 H, CH), 3.60 (s, 3 H, OMe), 4.92 (d, 1 H), 6.50-6. 70 (m, 3H), 7.10-7. 30 (m, 2H), 7.30-7. 5 (m, 8H), 7.75 (m, 4H), 8. 1 (d, 1 H). e) (2S)-2-Ethanesulfonylamino-N- (4'-hydroxy-3'-methoxy-biphenyl-2-yl)-3-methyl- butyramide A solution of 4.14 g (6.42 mmol) (2S)-N- [4'- (tert-butyl-diphenyi-silanyloxy)-3'-methoxy- biphenyl-2-yl]-2-ethanesulfonylamino-3-methyl-butyramide, 4.19 g (-16. 05 mmol) tetrabutyl- ammonium fluoride in 30 ml THF is stirred for 18 hours at room temperature. After extrac- ting with water/ethyl acetate and evaporation of the organic phase, the residue is subjected to flash-chromatography (ethyl acetate/hexane 4: 6). (2S)-2-Ethanesulfonylamino- N- (4'-hydroxy-3'-methoxy-biphenyl-2-yl)-3-methyl-butyramide is isolated as a yellow foam.

1H-NMR (CDCI_, 300 MHz) : 0.85-1. 05 (dd, 6H, 2 Me), 1.35 (t, 3H, Me), 1. 9 (m, 1 H, CH), 2.90, (q, 2H, CH2), 3.61 (m, 1 H, CH), 3.92 (s, 3 H, OMe), 5.00 (d, 1 H), 5.80 (s, 1 H), 6.70 (m, 2H), 7.00-7. 10 (m, 1H), 7.15-7. 30 (m, 2H), 7.45 (m, 1H), 7.62 (s, 1H), 8.27 (d, 1H).

A solution of 610 mg (1.5 mmol) (2S)-2-ethanesulfonylamino-N- (4'-hydroxy-3'-metho- xy-biphenyl-2-yl)-3-methyl-butyramide, 311 mg (2.25 mmol) K2CO3 and 0.8 ml (10.66 mmol) propargyl bromide in 20 ml acetonitrile is heated to reflux for 30 minutes. After usual work- up the product is subjected to flash-chromatography (ethyl acetate/hexane 4: 6) to yield (2S)-2-ethanesulfonylamino-N- (3'-methoxy-4'-prop-2-ynyloxy-biphenyl-2-yl)-3-methyl- butyramide as yellow solid (m. p. 97-103°C).

According to the example A1. 1 described above the compounds listed in table A1 are obtained.

Table A1 : No. Ri R3 Config R6 physico-chemical data a-C A1. 01 C2H5 C3H7-i (S)-CH2-C-CH m. p. 97-103 A1. 02 C2H5 C3H7-i (S) H 1H-NMR (CDCl3)#(ppm) : 0.85-1. 05 (dd, 6H), 1.35 (t, 3H), 1.9 (m, 1H), 2.90, (q, 2H), 3.61 (m, 1H), 3.92 (s, 3 H), 5.00 (d, 1H), 5.80 (s, 1H), 6.70 (m, 2H), 7.00-7. 10 (m, 1H), 7.15- 7.30 (m, 2H), 7.45 (m, 1H), 7.62 (s, 1H), 8.27 (d, 1H). A1. 03 C2H5 C3H7-i (S)-Si (C4H9-t) (C6H5) 2 1H-NMR (CDCl3), #(ppm) : 0.8 - 1.0 (dd, 6H), 1.15 (s, 9 H), 1.35 (t, 3H), 1.9 (m, 1H), 2.90 (dd, 2H), 3.55 (m, 1H), 3.60 (s, 3H), 4.92 (d, 1H), 6.50 - 6. 70 (m, 3H), 7.10-7. 30 (m, 2H), 7.30-7. 5 (m, 8H), 7.75 (m, 4H), 8. 1 (d, 1H). A1. 04 (CH3) 2N C3H7-i (S)-Si (C4Hg-t) (C6H5) 2 1H-NMR (CDCl3), # (ppm): 0.8-1. 0 (dd, 6H), 1.15 (s, 9 H), 1.9 (m, 1H), 2.65 (s, 6H), 3.40 (m, 1H), 3.60 (s, 3 H), 4.90 (d, 1H), 6.50-6. 70 (m, 3H), 7.10-7. 30 (m, 2H), 7.30-7. 5 (m, 8H), 7.75 (m, 4H), 8.30 (d, 1H). A1. 05 C2H5 C3H7-i (S) C2H5'H-NMR (CDCl3), # (ppm): 0.8-1. 0 (dd, 6H), 1.35 (t, 3H), 1, 50 (t, 3H), 2.0 (m, 1H), 2.90 (m, 2H), 3.70 (m, 1 H), 3.90 (s, 3 H), 4.15 (q, 2H), 4.95 (d, 1H), 6.85 (m, 2H), 7.00 (m, 1H), 7.15-7. 30 (m, 2H), 7.35 (dt, 1H), H),7. 60 (s, 1H), 8.3 (d, 1H). A1. 06 (CH3) 2N C3H7-i (S) -CH2-(3,4-Cl2-C6H3) 1H-NMR (CDCl3), #(ppm) : 0. 8-1. 0 (dd, 6H), 2.0 (m, 1H), 2.70 (s, 6H), 3.45 (m, 1H), 3.90 (s, 3H), 5.15 (d, 2H), 6.80-7. 00 (m, 3H), 7.15-7. 40 (m, 4H), 7.42-7. 50 (d, 1H), 7.55 (m, 2H), 8.30 (d, 1H). A1. 07 (CH3) 2N C3H7-i (S) -CH2-C#CH 1H-NMR (CDCl3), # (ppm): 0.8-1. 0 (dd, 6H), 2.0 (m, 1H), 2.55 (m, 1H), 2. 75 (s, 6H), 3.45 (m, 1H), 3.90 (s, 3 H), 4.85 (s, 2H), 6.85-6. 95 (m, 2H), 7.10-7. 30 (m, 3H), 7.45 (m, 1H). 7.55 (s, 1H), 8.30 (d, 1H). A1. 08 C2H5 4-Cl- (R, S) -CH2-C#CH 1H-NMR (CDCl3), #(ppm) : 1.2 (t, 3H), 2.4 (m, 1 H), 2.55 (m, 2H), 2.75 (s, C6H5 6H), 3.45 (m, 1H), 3.90 (s, 3H), 4.85 (s, 2H), 4. 95 (s, 1H), 5.85 (d, 1H), 6.5 (d, 1H), 6.6 (s, 1H), 6.95 (d, 1H), 7.10-7. 40 (m, 8H), 8.30 (d, 1H). A1. 09 C2H5 4-Cl- (R, S) H 1H-NMR (CDCl3), #(ppm) : 1.2 (t, 3H), C6H5 2. 5-2.8 (2m, 2H), 3.77 (s, 3H), 4.95 6H5 (s, 1 H), 5.75 (s, 1 H), 5.85 (m, 1 H), 6.5 (m, 2H), 6.85 (d, 1H), 7.15- 7.40 (m, 8H), 8.30 (d, 1H). A1.10 C2H5 C3H7-i (S) -CH2-C#C-(4-Cl-C6H4) 1H-NMR (CDCl3), # (ppm): 0.8 - 1. 0 (dd, 6H), 1.15 (t, 3H), 2.0 (m, 1H), 2.90 (q, 2H), 3.60 (m, 1 H), 3.90 (s, 3H), 4.95 (d, 1 H), 5.15 (m, 2H), 6. 90 (m, 2H), 6.85 (d, 2H), 7.15-7. 45 (m, 8H), 7.60 (s, 1H), 8.30 (d, 1H). A1. 11 C2H5 C3H7-i (S) -CH2-C6H5 1H-NMR (CDCl3) # (ppm): 0.85 (d, 3H); 0.95 (d, 3H); 1.3 (t, 3H) 1.9-2. 1 (m, 1H) ; 2.9 (q, 2H); 3.6 (dd, 1H) ; 3.9 (s, 3H); 4.95 (d, 1H) ; 5.2 (s, 2H); 6.75 - 6. 9 (m, 2H); 7.0 (d, 1H) ; 7.1 - 7. 6 (m, 9H) ; 8.25 (d, 1H). A1. 12 C2H5 C3H7-i (S)-CH2- (4-OCF3-C6H4) m. p. 140-141°C A1.13 C2H5 C3H7-i (S) -CH2-C#C-C6H5 m.p. 67-68°C A1.14 C2H5 C3H7-i (S) -CH2-C#C-(4-Cl-C6H4) 1H-NMR (CDCl3) #(ppm) : 0.85 (d, 3H); 0.95 (d, 3H); 1.3 (t, 3H); 1.9-2. 1 (m, 1H) ; 2.9 (q, 2H); 3.6 (dd, 1H) ; 3.9 (s, 3H); 4.95 (d, 1 H) ; 5.05 (s, 2H); 6.8 - 7. 0 (m, 2H); 7.1-7. 4 (m, 8H) ; 7.6 (s, 1H ; 8. 25 (d, 1H). A1. 15 C2H5 C3H7-i (S)-CH2-C=C- (4-F-C6H4) m. p. 127-129 °C A1. 16 C2H5 C3H7-i (S) -CH2-C#C-(4-Br-C6H4) 1H-NMR (CDCl3) #(ppm) : 0.85 (d, 3H); 0. 95 (d, 3H); 1.3 (t, 3H); 1.9-2. 1 9 (m, 1H) ; 2.9 (q, 2H); 3.6 (dd, 1H) ; 3.9 (s, 3H); 4.9-5. 05 (m, 3H); 6.8- 6.95 (m, 2H); 7.1-7. 5 (m, 8H) ; 7.6 (s, 1H); 8.25 (d, 1H). A1. 17 C2H5 C3H7-i (S)-CH2-CH2-O-C6H5 m. p. 126-128 °C A1. 18 C2H5 C3H7-i (S) -CH2-CH2-O-(4-F-C6H4) m. p. 117-118 °C A1. 19 C2H5 C3H7-i (S) -CH2-CH2-O-(4-Cl-C6H4) 1H-NMR (CDCl3) # (ppm): 0. 9 (d, 3H); 1. 0 (d, 3H); 1.35 (t, 3H); 1.95-2. 1 (m, 1H) ; 2.9 (q, 2H); 3.6 (dd, 1H) ; 3.9 (s, 3H); 4.4-4. 6 (m, 4H); 4.95 (d, 1H) ; 6.8-6. 95 (m, 3H); 7.05 (d, 1 H) ; 7.15-7. 45 (m, 6H) ; 7.65 (s, 1H ; 8.3 (d, 1H). A1. 20 C2H5 C3H7-i (S) C2H5 Oil A1.21 C2H5 C3H7-i (S) -CH2=C#C-CH3 1H-NMR (CDCl3) #(ppm): 0. 9 (d, 3H); 0.95 (d, 3H); 1.3 (t, 3H); 1.9 (t, 3H); 1. 95- 2.15 (m, 1H) ; 2.9 (q, 2H) ; 3.6 (dd, 1 H) ; 3.9 (s, 3H); 4.75 (d, 2H); 5.05 (d, 1 H) ; 6.8-6. 95 (m, 2H); 7.1-7. 4 (m, 4H); 7.6 (s, 1H ; 8.25 (d, 1H). A1. 22 C2H5 C3H7-i (S)-CH2-C=C- (4-CH3-C6H4) Oil A1. 23 CH3 C3H7-i (S) -CH2-C#C-CH2-CH2-CH3 m. p. 52-55 °C A1.24 C2H5 C3H7-i (S) -CH2-C#C-CH2-CH3 1H-NMR (CDCl3) # (ppm): 0. 9 (d, 3H); 1.0 (d, 3H); 1.15 (t, 3H); 1.3 (t, 3H); 1. 9-2. 1 (m, 1 H); 2.15-2. 3 (m, 2H); 2.9 (q, 2H); 3.4 (dd, 1H) ; 3.9 (s, 3H); 4.9 (t, 2H); 5.0 (d, 1 H); 6. 8-6. 95 (m, 2H); 7.1 - 7. 4 (m, 4H); 7.6 (s, 1 H) ; 8. 25 (d, 1H). A1. 25 C2H5 C3H7-i (S)-CH2-C-C-CH2-CH2-CH3 Resin A1. 26 CH3 C3H7-i (S) -CH2-C#C-CH2-CH2-CH2-CH3 Oil A1. 27 C2H5 C3H7-i (S) -CH2-C#C-CH2-CH2-CH2-CH3 1H-NMR (CDCl3) #(ppm): 0.8-1. 0 (m, 9H); 1. 5-1. 6 (m, 7H); 1.9-2. 1 (m, 1H) ; 2.15-2. 3 (m, 2H); 2.9 (q, 2H); 3.6 (dd, 1 H) ; 3.9 (s, 3H); 4.8 (t, 2H); 5.05 (d, 1 H) ; 6.8-6. 9 (m, 2H); 7.1-7. 4 (m, 4H); 7.6 (s, 1 H) ; 8,25 (d, 1H). A1. 28 CH3 C3H7-i (S)-CH2-C-C-CH2-CH3 m. p. 138-139 °C A1. 29 CH3 C3H7-i (S) -CH2-C#C-C6H5 m. p. 168-170 °C A1. 30 CH3 C3H7-i (S) -CH2-C#C-(4-F-C6H4) m. p. 155-156 °C A1. 31 CH3 C3H7-i (S)-CH2-CEC- (4-CH3-C6H4) m. p. 117-121 °C A1. 32 CH3 C3H7-i (S)-CH2-C6H5 m. p. 62-65 °C A1. 33 CH3 C3H7-i (S) C2H5 m. p. 95-98 °C A1. 34 CH3 C3H7-i (S) -CH2-C#C-CH3 m. p. 132-134 °C A1. 35 CH3 C3H7-i (S)-CH2- (4-OCF3-C6H4) m. p. 165-168 °C Al. 36 CH3 C3H7-i (S)-CH2-C=C- (4-CI-C6H4) m. p. 120-122 °C A1. 37 CH3 C3H7-i (S) -CH2-CH2-O-C6H5 m. p. 132-136 °C A1.38 CH3 C3H7-i (S) -CH2-CH2-O-(4-F-C6H4) m. p. 58-60 °C A1. 39 (CH3) 2N C3H7-i (S) C2H5 Oil A1. 40 (CH3) 2N C3H7-i (S)-CH2- (4-OCF3-C6H4) m. p. 141-142 °C A1. 41 (CH3) 2N C3H7-i (S)-CH2-C-C-C6H5 m. p. 75-78 °C A1. 42 (CH3) 2N C3H7-i (S) -CH2-C#C-(4-Cl-C6H4) m. p. 66-68 v A1. 43 (CH3) 2N C3H7-i (S) -CH2-C#C-(4-F-C6H40) m. p. 78-81 °C A1. 44 (CH3) 2N C3H7-i (S)-CH2-C=-C- (4-Br-C6H4) m. p. 77-79 °C A1. 45 (CH3) 2N C3H7-i (S) -CH2-CH2-O-C6H5 m. p. 128-131 °C A1. 46 (CH3) 2N C3H7-i (S) -CH2-CH2-O-(4-Cl-C6H4) m. p. 53-55 °C A1. 47 CH3 C3H7-i (S) CH3 m. p. 68-70 °C A1. 48 CH3 C3H7-i (S) -CH2-C#C-(4-Br-C6H4) m. p. 77-79 °C A1. 49 CH3 C3H7-i (S)-CH2-CH2-O-(4-CI-C6H4) m. p. 130-131 °C A1. 50 CzH5 C3H7-i (S) CH3'H-NMR (CDC13) S (ppm) : 0. 9 (d, 3H); 1.0 (d, 3H); 1.35 (t, 3H); 1.9-2. 1 (m, 1H) ; 2.9 (q, 2H); 3.6 (dd, 1H) ; 3.9 (s, 3H); 3.95 (s, 3H); 5.0 (d, 1H) ; 6.8-7. 05 (m, 3H); 7.15 - 7. 4 (m, 3H); 7.6 (s, 1H) ; 8.3 d, 1H). A1. 51 (CH3) 2N C3H7-i (S) CH3 1H-NMR (CDCl3) #(ppm) : 0. 9 (d, 3H); 0.95 (d, 3H); 1.9 - 2. 05 (m, 1H) ; 2.7 (s, 6H); 3.45 (dd, 1H) ; 3.9 (s, 3H); 3.95 (s, 3H); 4.95 (d, 1H) ; 6.8-7. 05 (m, 3H) ; 7.15- 7.4 (m, 3H); 7.6 (s, 1H) ; 8.35 (d, 1H). A1. 52 (CH3) 2N C3H7-i (S)-CH2-C_C-CH3 m. p. 46-48 °C A1. 53 (CH3) 2N C3H7-i (S) -CH2-C#C-CH2-CH3 1H-NMR (CDCl3) #(ppm) : 0. 9 (d, 3H); 0.95 (d, 3H); 1.15 (t, 3H); 1.9-2. 1 (m, 1H) ; 2.15-2. 3 (m, 2H); 2.7 (s, 6H); 3.5 (dd, 1H) ; 3.9 (s, 3H); 4.3 (t, 2H); 5.05 (d, 1H) ; 6.8-6. 95 (m, 2H); 7.1- 7.45 (m, 4H); 7.6 (s, 1H) ; 8.3 (d, 1H). A1.54 (CH3)2N C3H7-i (S) -CH2-C#C-CH2-CH2-CH3 Oil A1.55 (CH3)2N C3H7-i (S) -CH2-C6H5 Oil A1. 56 (CH3) 2N C3H7-i (S)-CH2-C=C- (4-CH3-C6H4) m. p. 64-67 °C -CH2-CH2-0- (4-F-C6H4) Oil A1. 58 (CH3) 2N C3H7-i (S) -CH2-C#C-C6H11-cycl 1H-NMR (CDCl3) #(ppm) : 0.85 (d, 3H); 0.95 (d, 3H); 1.2-1. 85 (m, 13 H) ; 1.9- 2.1 (m, 1H) ; 2.3-2. 5 (m, 1H) ; 2.9 (q, 2H); 3.6 (dd, 1 H) ; 3.85 (s, 3H); 4.8 (t, 2H); 5.1 (d, 1H) ; 6.8-6. 95 (m, 2H); 7. 1-7. 4 (m, 4H); 7.7 (s, 1H ; 8.25 (d, 1H). A1. 59 C2H5 C3H7-i (S) -CH2-(3,4-Cl2-C6H3) m. p. 160-161 °C A1. 60 CH3 CH2-C#CH (R, S) CH3 Oil A1. 61 CH3 C4H9-i (S) CH3 Oil A1. 62 CH3 C2H5 (S) CH3 Oil A1. 63 CH3 CH2-CH=CH2 (R, S) CH3 Oii A1. 64 CH3 C3H5-cycl (R, S) CH3 m. p. 153-154 °C A1. 65 CH3 H - CH3 m. p. 158-160 °C According to the example A1. 1 above the compounds listed in table A2 are obtained.

Table A2 : No. R, R3 Config R6 physico-chemical data a-C A2.01 C2H5 C3H7-i (S) -Si (C4H9-t) (C6H5) 2 m. p. 100-102 °C A2.02 (CH3) 2N C3H7-i (S) -Si (C4H9-t) (C6H5) 2'H-NMR (CDCI3), 8 (ppm) : 0.95- 1.1 (dd, 6H), 1.15 (s, 9 H), 2.2 (m, 1H), 2.80 (s, 6H), 3.60 (s, 3H), 3. 75 (m, 1H), 5.18 (d, 1H), 6.70 (d, 1H), 6.85 (dd, 1H), 7.0 (m, 1H), 7.15-7. 50 (m, 9H), 7.65 (s, 1H), 7.75 (m, 4H), 8.0 (s, 1H). A2.03 C2H5 C3H7-i (S) H m. p. 187-189. 5 °C A2.04 (CH3) 2N C3H7-i (S) H m. p. 185-188.5 °C A2.05 C2H5 C3H7-i (S)-CH2- (3, 4-CI2-C6H3) m. p. 146-149 °C A2.06 C2H5 C3H7-i (S) -CH2-C#CH m. p. 178-180 °C A2.07 C2H5 C3H7-i (S) C2H5 m. p. 202-203 °C A2.08 (CH3) 2N C3H7-i (S) -CH2-C#CH m. p. 131-136 °C A2.09 (CH3) 2N C3H7-i (S) -CH2-(3,4-Cl2-C6H3) 1H-NMR (CDCl3), # (ppm): 0.9- 1.1 (dd, 6H), 2.15 (m, 1H), 2.70 (s, 6H), 3.75 (m, 1 H), 3.95 (s, 3 H), 5.10 (s, 2H), 6.80 (d, 1H), 7.00-7. 10 (m, 2H), 7.20-7. 50 (m, 5H), 7.55 (d, 1 H), 7.70 (s, 1H), 7.95 (s, 1H). According to the example A1. 1, above the compounds listed in table A3 are obtained.

Table A3: No. Ri R3 Config R6 physico-chemical data a-C A3. 01 C2H5 C3H7-i (S) -Si (C4H9-t) (C6H5) 2 1H-NMR (CDCl3), # (ppm): 0.95- 1.1 (dd, 6H), 1.15 (s, 9H), 1.38 (t, 3H), 2.15 (m, 1H), 3.15 (m, 2H), 3.60 (s, 3H), 3.85 (m, 1H), 5.30 (d, 1H), 6.65-7. 00 (3m, 3H), 7.30-7. 50 (m, 8H), 7.5 (m, 2H), 7.75 (m, 4H), 8.2 (s, 1H). A3.02 (CH3) 2N C3H7-i (S) -Si (C4H9-t) (C6H5) 2'H-NMR (CDCI3), 8 (ppm) : 0. 90- 1.1 (dd, 6H), 1.15 (s, 9 H), 2.20 (m, 1H), 2,70 (s, 6H), 3.60 (s, 3H), 3.70 (m, 1H), 5.15 (d, 1H), 6.70 (d, 1H), 6.80 (m, 1H), 6.95 (m, 1H), 7.30-7. 45 (m, 8H), 7. 55 (d, 2H), 7.75 (m, 4H), 7.95 (s, 1H). A3.03 C2H5 C3H7-i (S) H m. p. 191-192 °C A3.04 (CH30 2N C3H7-i (S) H m. p. 187. 5-188.5 °C A3.05 C2H5 C3H7-i (S)-CH2- (3, 4-CI2-C6H3) m. p. 201-202 °C A3.06 C2H5 C3H7-i (S) C2H5 m. p. 182-184 °C A3.07 (CH3) 2N C3H7-i (S) -CH2-C#CH m. p. 148-150 °C A3.08 (CH3) 2N C3H7-i (S) C2H5 m. p. 186-187 °C A3.09 (CH3)2N C3H7-i (S) -CH2-(3,4-Cl2-C6H3) m. p. 201-202 °C Example A1. 2: (2S)-2-Ethanesulfonylamino-N-[trans-2-(3-methoxy-4-prop-2-yn yloxy- phenyl)-cyclohexyl]-3-methyl-butyramide a) trans-2-Methoxy-4-(6-nitro-cyclohex-3-enyl)-phenol A solution of 50 g (0.25 mol) of 4-hydroxy-3-methoxy-ß-nitrostyrene and 1.0 g (9.1 mmol) of hydrochinone in 200ml toluene is cooled to-78°C and 55 g (1.02 mol) of 1,3-butadiene is added. This mixture is transferred into an autoclave and stirred at +130°C for 4 days.

Subsequently, the toluene is evaporated in vacuum. The dark brown oil is purified by crystallization from ethanol to obtain trans-2-methoxy-4- (6-nitro-cyclohex-3-enyl)-phenol.

1H-NMR fCDCk 300 MHz): 2.28-2. 83 (m, 4H, CH2), 3.34 (td, 1 H), 3.87 (s, 3H, OCH3), 4.89 (td, 1 H), 5.53 (s, 1 H, OH), 5. 71-5. 84 (m, 2H, CH=CH), 6.69 (d, 1 H, ar), 6.73 (dd, 1 H, ar), 6.85 (d, 1 H, ar). b) trans-2-Methoxy-4-(2-nitro-cyclohexyl)-phenol trans-2-Methoxy-4- (6-nitro-cyclohex-3-enyl)-phenol (8.4 g, 33.7 mmol) is dissolved in 300 ml methanol and 500 mg of 10 % Pd/C is added. The mixture is hydrogenated at room temperature for 6 hours. The mixture is then filtered through Celite and evaporation of the filtrate in vacuum gives trans-2-methoxy-4- (2-nitro-cyclohexyl)-phenol as a light yellow solid.

'H-NMR (CDCl3, 300 MHz) : 1.40-2. 40 (m, 8H, CH2), 3.05 (td, 1H), 3.85 (s, 3H, OCH3), 4.62 (td, 1H), 6.65 (d, 1H, ar), 6.69 (dd, 1H, ar), 6.83 (d, 1H, ar). c) trans-4- (2-Amino-cyclohexyl)-2-methoxy-phenol trans-2-Methoxy-4- (2-nitro-cyclohexyl)-phenol (8.5 g, 33.8 mmol) is dissolved in 300 mi methanol. To this mixture are added simultaneously 7ml of hydrazine hydrate and 2.5 g of Raney-Nickel over 8 hours with vigorous stirring. Upon completion of the addition the reaction mixture is stirred for 16 hours at room temperature. The mixture is then filtered and evaporation of the solvent in vacuum gives trans-4- (2-amino-cyclohexyl)-2-methoxy-phenol as a lightyellowsolid. 1H-NMR (CDCIF,. 300 MHz): 1.20-2. 10 (m, 8H, CH2), 2.17 (td, 1H), 2.77 (td, 1 H), 3.87 (s, 3H, OCH3), 6.72 (d, 1 H, ar), 6.79 (dd, 1 H, ar), 6.89 (d, 1 H, ar). d) (2S)-2-Ethanesulfonylamino-N-[trans-2-(4-hydroxy-3-methoxy-p henyl)-cycloheXyl]-3-<BR> methyl-butyramide To a stirred solution of N-ethylsulfonyl-L-valine (1. 3 g, 6.2 mmol), trans-4- (2-amino-cyclo- hexyl)-2-methoxy-phenol (1.23 g, 5.6 mmol) and N, N-diisopropylethylamine (0.76 g, 5.9 mmol) in 20 ml N, N-dimethylformamide is added 2.6 g (5.9 mmol) of benzotriazol-1-yloxy- tris (dimethylamino) phosphonium hexafluorophosphate in one portion. The reaction mixture is then stirred at ambient temperature for about 2 hours and subsequently poured into 150 ml of aqueous saturated sodium chloride solution. The mixture is extracted with two 150 ml portions of ethyl acetate. The extract is concentrated under reduced pressure to give a residue, which is subjected to column chromatography on silica gel, with 1: 1 ethyl acetate /i-hexane as the eluant yielding (2S)-2-ethanesulfonylamino-N- [trans-2- (4-hydroxy-3- methoxy-phenyl)-cyclohexyl]-3-methyl-butyramide. H-NMR (CDCI, 300 MHz) : 0.79 (d, 3H, CH3), 0.92 (d, 3H, CH3), 1. 10 (t, 3H, CH3), 1.20-2. 88 (m, 12H), 3.38 (dd, 1 H), 3.87 (s, 3H, OCH3), 3.98-4. 15 (m, 1 H), 4.95 (d, 1 H), 5.42 (d, 1 H), 6.62-. 6.81 (m, 3H, ar). e) A solution of (2S)-2-ethanesulfonylamino-N- [trans-2- (4-hydroxy-3-methoxy-phenyl)- cyclohexyl]-3-methyl-butyramide (1.0 g, 2.43 mmol), propargyl bromide (0.42 g, 3.6 mmol) and 4.6 ml of 1 M solution of sodium methoxide inl 6 ml methanol is refluxed for 3 hours.

The reaction mixture is cooled and poured into 30 ml of aqueous saturated sodium chloride solution. The mixture is extracted with two 100 ml portions of ethyl acetate and the extract is concentrated under reduced pressure to a residue, which is subjected to column chromato- graphy on silica gel, with 1: 1 ethyl acetate/ !-hexane as the eluant to obtain (2S)-2-ethane- sulfonylamino-N- [trans-2- (3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]-3-methyl- butyramide. 1H-NMR (CDCI3, 300 MHz): 0.78 (d, 3H, CH3), 0.93 (d, 3H, CH3), 1.10 (t, 3H, CH3), 1.21-2. 00 (m, 8H), 2.12 (sep, 1 H), 2.24 (dq, 1 H), 2.37 (td, 1 H), 2.40 (dq, 1 H), 2.51 (t, 1 H, C-CH), 3.29 (dd, 1H), 3.86 (s, 3H, OCH3), 4.12 (m, 1H), 4.72 (d, 2H, CH2C#C), 4. 80 (d, 1 H), 5.40 (d, 1H), 6.72 (dd, 1 H, ar), 6.77 (d, 1 H, ar), 6.92 (d, 1 H, ar).

According to the example A1. 2 above the compounds listed in table A4 are obtained.

Table A4: No. Ri R3 Config a-C R6 physico-chemical data A4.01 C2H5 C3H7-i (S)-CH2-C-CCH2CH3 m. p. 133-136 A4.02 CH3 C3H7-i (S) CH3 m. p. 158-164 A4.03 (CH3) 2N C3H7-i (S) CH3 m. p. 182-184 A4.04 (CH3)2N C3H7-i (S) -CH2-C#CH Oil A4.05 C2H5 | C3H7-i (S) H Oil A4.06 C2H5 C3H7-i (S) CH3 Oil A4.07 (CH3) 2N C3H7-i (S)-CH2-C=-CCH2CH3 m. p. 158-160 A4.08 (CH3) 2N C3H7-i (S) H Oil A4.09 CH3 C3H7-i (S) -CH2-C#CH m. p. 183-185 A4. 10 CH3 C3H7-i (S)-CH2-C=CCH2CH3 m. p. 166-168 A4.11 C2H5 C3H7-i (S) -CH2-C#CH m. p. 149-151 Analogously to the above Examples the following compounds of Tables 1 to 44 may be prepared. In the tables Ph means phenyl. Table 1: Compounds represented by the Formula 1. 1 wherein the combination of the groups RI, R4, R5 and R6 corresponds to each row in table A. Table 2: Compounds represented by the Formula 1. 2 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 3 : Compounds represented by the Formula 1. 3 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 4 : Compounds represented by the Formula 1. 4 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 5: Compounds represented by the Formula 1. 5 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 6: Compounds represented by the Formula 1. 6 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 7: Compounds represented by the Formula 1. 7 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 8: Compounds represented by the Formula 1. 8 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 9: Compounds represented by the Formula 1. 9 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 10 : Compounds represented by the Formula 1. 10 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 11 : Compounds represented by the Formula 1. 11 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 12: Compounds represented by the Formula 1. 12 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 13 : Compounds represented by the Formula 1. 13 wherein the combination of the groups Rt, R4, R5 and R6 corresponds to each row in table A. Table 14 : Compounds represented by the Formula 1. 14 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 15: Compounds represented by the Formula 1. 15 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 16: Compounds represented by the Formula 1. 16 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 17 : Compounds represented by the Formula 1. 17 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 18: Compounds represented by the Formula 1. 18 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 19: Compounds represented by the Formula 1. 19 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 20: Compounds represented by the Formula 1. 20 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 21: Compounds represented by the Formula 1. 21 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 22: Compounds represented by the Formula 1. 22 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 23 : Compounds represented by the Formula 1. 23 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 24: Compounds represented by the Formula 1. 24 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 25: Compounds represented by the Formula 1. 25 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 26: Compounds represented by the Formula 1. 26 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 27: Compounds represented by the Formula 1. 27 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 28: Compounds represented by the Formula 1. 28 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 29: Compounds represented by the Formula 1. 29 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 30: Compounds represented by the Formula 1. 30 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 31 : Compounds represented by the Formula 1. 31 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 32: Compounds represented by the Formula 1. 32 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 33: Compounds represented by the Formula 1. 33 wherein the combination of the groups R1, R4, R5 and R6 corresponds to each row in table A. Table 34: Compounds represented by the Formula 1. 34 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 35: Compounds represented by the Formula 1. 35 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 36: Compounds represented by the Formula 1. 36 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 37: Compounds represented by the Formula 1. 37 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 38: Compounds represented by the Formula 1. 38 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 39: Compounds represented by the Formula 1. 39 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 40: Compounds represented by the Formula 1. 40 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 41 : Compounds represented by the Formula 1. 41 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 42: Compounds represented by the Formula 1. 42 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 43: Compounds represented by the Formula 1. 43 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A. Table 44 : Compounds represented by the Formula 1. 44 wherein the combination of the groups Ri, R4, R5 and R6 corresponds to each row in table A.

Table A Ph designates a phenyl ring No. Ri R4 Rs R6 001 CH3-H-H--H 002 CH3-H-H--CH3 003 CH3-H-H--CH2-CH3 004 CH3-H-H--CH2-CH2-CH3 005 CH3-H-H--CH2-CH=CH2 006 CH3-H-H--CH2-CH=CH-CH3 007 CH3- H- H- -CH2-(CH3) C=CH2 008 CH3-H-H--CH2-CH=CHCI 009 CH3- H- H- -CH2-C#CH 010 CH3- H- H- -CH2-C#C-CH3 011 CH3- H- H- -CH2-C#C-CH2-CH3 012 CH3-H-H--CH2-C=-C- (CH2) 2-CH3 013 CH3-H-H--CH2-C-C-C3H5-cycl 014 CH3-H-H--CH2-C=C-C5H9-cycl 015 CH3- H- H- -CH2-C#C-C6H11-cycl 016 CH3-H-H--CH2-Ph 017 CH3-H-H--CH2- (3-CI-Ph) 018 CH3- H- H- -CH2-(4-Cl-Ph) 019 CH3-H-H--CH2- (3, 4-CI2-Ph) 020 CH3-H-H--CH2- (3-CF3-Ph) 021 CH3- H- H- -CH2-C#C-Ph 022 CH3-H-H--CH2-C=-C- (4-CH3-Ph) 023 CH3- H- H- -CH2-C#C-(4-Cl-Ph) 024 CH3- H- H- -CH2-C#C-(4-F-Ph) 025 CH3- H- H- -CH2-C#C-(4-Br-Ph) 026 CHs-H-H--CHz-CHz-O-Ph 027 CH3- H- H- -CH2-CH2-O-(4-F-Ph) 028 CH3-H-H--CH2-CH2-O- (4-CI-Ph) 029 CH3-CH2-H-H--H 030 CH3-CH2-H-H--CH3 031 CH3-CH2-H-H--CH2-CH3 032 CH3-CH2-H-H--CH2-CH2-CH3 033 CH3-CH2-H-H--CH2-CH=CH2 034 CH3-CH2-H-H--CH2-CH=CH-CH3 035 CH3-CH2-H-H--CH2- (CH3) C=CH2 036 CH3-CH2-H-H--CH2-CH=CHCI 037 CH3-CH2- H- H- -CH2-C3CH 038 CH3-CH2- H- H- -CH2-C#C-CH3 039 CH3-CH2-H-H--CH2-C=C-CH2-CH3 040 CH3-CH2- H- H- -CH2-C#C-(CH2)2-CH3 041 CH3-CH2- H- H- -CH2-C#C-C3H5-cycl 042 CH3-CH2-H-H--CH2-C=C-C5H9-cycl 043 CH3-CH2- H- H- -CH2-C#C-C6H11-cycl 044 CH3-CH2-H-H--CH2-Ph 045 CH3-CH2-H-H--CH2- (3-Cf-Ph) 046 CH3-CH2-H-H--CH2- (4-CI-Ph) 047 CH3-CH2- H- H- -CH2-(3,4-Cl2-Ph) 048 CH3-CH2- H- H- -CH2-(3-CF3-Ph) 049 CH3-CH2-H-H--CH2-C=C-Ph 050 CH3-CH2- H- H- -CH2-C#C-(4-CH3-Ph) 051 CH3-CH2- H- H- -CH2-C#C-(4-Cl-Ph) 052 CH3-CH2-H-H--CH2-C=C- (4-F-Ph) 053 CH3-CH2-H-H--CH2-C=-C- (4-Br-Ph) 054 CH3-CH2-H-H--CH2-CH2-O-Ph 055 CH3-CH2- H- H- -CH2-CH2-O-(4-F-Ph) 056 CH3-CH2- H- H- -CH2-CH2-O-(4-Cl-Ph) 057 (CH3) 2N- H- H- -H 058 (CH3) 2N- H- H- -CH3 059 (CH3) 2N- H- H- -CH2-CH3 060 (CH3) 2N- H- H- -CH2-CH2-CH3 061 (CH3) 2N- H- H- -CH2-CH=CH2 062 (CH3) 2N- H- H- -CH2-CH=CH-CH3 063 (CH3) 2N- H- H- -CH2-(CH3)C=CH2 064 (CH3) 2N- H- H- -CH2-CH=CHCH 065 (CH3) 2N- H- H- -CH2-C#CH 066 (CH3) 2N- H-H--CH2-C=-C-CH3 067 (CH3) 2N- H-H--CH2-C=C-CH2-CH3 068 (CH3) 2N- H- H- -CH2-C#C-(CH2) 2-CH3 069 (CH3) 2N- H-H--CH2-C=C-C3H5-cycl 070 (CH3)2N- H- H- -CH2-C#C-C5H9-cycl 071 (CH3) 2N- H- H- -CH2-C#C-C6H11-cycl 072 (CH3) 2N- H-H--CH2-Ph 073 (CH3) 2N- H-H--CH2- (3-CI-Ph) 074 (CH3) 2N- H- H- -CH2-(4-Cl-Ph) 075 (CH3) 2N- H-H--CH2- (3, 4-CI2-Ph) 076 (CH3) 2N- H-H--CH2- (3-CF3-Ph) 077 (CH3) 2N- H-H--CH2-C=C-Ph 078 (CH3) 2N- H- H- -CH2-C#C-(4-CH3-Ph) 079 (CH3) 2N- H- H- -CH2-C#C-(4-Cl-Ph) 080 (CH3) 2N- H- H- -CH2-C#C-(4-F-Ph) 081 (CH3)2N- H- H- -CH2-C#C-(4-Br-Ph) 082 (CH3) 2N-H-H--CH2-CH2-O-Ph 083 (CH3) 2N- H- H- -CH2-CH2-O-(4-F-Ph) 084 (CH3) 2N- H- H- -CH2-CH2-O-(4-Cl-Ph) 085 CH3-CH2- 3-CH3-O- H- H- 086 CH3-CH2- 3-CH3-O- H- -CH3 087 CH3-CH2- 3-CH3-O- H- -CH2-CH3 088 CH3-CH2-3-CH3-O-H--CH2-CH2-CH3 089 CH3-CH2- 3-CH3-O- H- -CH2-CH=CH2 090 CH3-CH2- 3-CH3-O- H- -CH2-CH=CH-CH3 091 CH3-CH2-3-CH3-O-H--CH2-(CH3) C=CH2 092 CH3-CH2-3-CH3-O-H--CH2-CH=CHCI 093 CH3-CH2-3-CH3-O-H--CH2-C=CH 094 CH3-CH2- 3-CH3-O- H- -CH3-C#C-CH3 095 CH3-CH2-3-CH3-O-H--CH2-C-C-CH2-CH3 096 CH3-CH2- 3-CH3-O- H- -CH2-C#C-(CH2)2-CH3 097 CH3-CH2-3-CH3-O-H--CH2-C=C-C3H5-cycl 098 CH3-CH2- 3-CH3-O- H- -CH2-C#C-C5H9-cycl 099 CH3-CH2- 3-CH3-O- H- -CH2-C#C-C6H11-cycl 100 CH3-CH2-3-CH3-O-H--CH2-Ph 101 CH3-CH2- 3-CH3-O- H- -CH2-(3-Cl-Ph) 102 CH3-CH2- 3-CH3-O- H- -CH2-(4-Cl-Ph) 103 CH3-CH2-3-CH3-0-H--CH2- (3, 4-CI2-Ph) 104 CH3-CH2-3-CH3-O-H--CH2-(3-CF3-Ph) 105 CH3-CH2-3-CH3-O-H--CH2-C=C-Ph 106 CH3-CH2-3-CH3-0-H--CH2-C=C- (4-CH3-Ph) 107 CH3-CH2- 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 108 CH3-CH2- 3-CH3-O- H- -CH2-C#C-(4-F-Ph) 109 CH3-CH2- 3-CH3-O- H- -CH2-C#C-(4-Br-Ph) 110 CH3-CH2-3-CH3-O-H--CH2-CH2-O-Ph 111 CH3-CH2-3-CH3-O-H--CH2-CH2-O- (4-F-Ph) 112 CH3-CH2- 3-CH3-O- H- -CH2-CH2-O-(4-Cl-Ph) 113 CH3-3-CH3-O-H--H 114 CH3-3-CH3-O-H--CH3 115 CH3- 3-CH3-O- H- -CF3 116 CH3- 3-CH3-O- H- CHF2 117 CH3- 3-CH3-O- H- -CH2-CH3 118 CH3-3-CH3-O-H--CH2-CH2-CH3 119 CH3- 3-CH3-O- H- -CH2-CH=CH2 120 CH3- 3-CH3-O- H- -CH2-CH=CH-CH3 121 CH3- 3-CH3-O- H- -CH2-(CH3) C=CH2 122 CH3- 3-CH3-O- H- -CH2-CH=CHCH 123 CH3-3-CH3-O-H--CH2-C=CH 124 CH3-3-CH3-O-H--CH (CH3)-C=CH 125 CH3- 3-CH3-O- H- -CH2-C#C-CF3 126 CH3- 3-CH3-O- H- -CH2-C#C-CH3 127 CH3-3-CH3-O-H--CH2-C=C-CH2-CH3 128 CH3- 3-CH3-O- H- -CH2-C#C-(CH2)2-CH3 129 CH3- 3-CH3-O- H- -CH2-C#C-(CH2)4-CH3 130 CH3- 3-CH3-O- H- -CH2-C#C-C3H5-cycl 131 CH3-3-CH3-0-H--CH2-C=-C-C5H9-cycl 132 CH3- 3-CH3-O- H- -CH2-C#C-C6H11-cycl 133 CH3-3-CH3-0-H--CH2-Ph 134 CH3- 3-CH3-O- H- -CH2-(3-Cl-Ph) 135 CH3- 3-CH3-O- H- -CH2-(4-F-Ph) 136 CH3- 3-CH3-O- H- -CH2-(4-Cl-Ph) 137 CH3-3-CH3-0-H--CH2- (4-Br-Ph) 138 CH3- 3-CH3-O- H- -CH2-(4-I-Ph) 139 CH3-3-CH3-0-H--CH2- (4-CH3-Ph) 140 CH3- 3-CH3-O- H- -CH2-(3-NO2-Ph) 141 CH3- 3-CH3-O- H- -CH2-(4-CN-Ph) 142 CH3- 3-CH3-O- H- -CH2-(4-CH3O-Ph) 143 CH3- 3-CH3-O- H- -CH2-(4-H2C=CH-Ph) 144 CH3-3-CH3-O-H--CH2- (4-CH3S-Ph) 145 CH3- 3-CH3-O- H- -CH2-(4-CF3S-Ph) 146 CH3- 3-CH3-O- H- -CH2-(3,4-Cl2-Ph) 147 CH3-3-CH3-O-H--CH2- (3-CF3-Ph) 148 CH3- 3-CH3-O- H- -CH2C#C-Ph 149 CH3-3-CH3-0-H--CH2-C=C- (4-CH3-Ph) 150 CH3- 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 151 CH3-3-CH3-O-H--CH2-C=C- (4-F-Ph) 152 CH3-3-CH3-O-H--CH2-C=C- (4-Br-Ph) 153 CH3-3-CH3-O-H--CH2-C=C- (3-CN-Ph) 154 CH3-3-CH3-0-H--CH2-C=C- (3, 4-CI2-Ph) 155 CH3- 3-CH3-O- H- -CH2-CH2-O-Ph 156 CH3-3-CH3-0-H--CH2-CH2-0- (4-F-Ph) 157 CH3-3-CH3-O-H--CH2-CH2-O- (4-CI-Ph) 158 CH3-3-CH3-0-H--CH2-CH2-0- (4-Br-Ph) 159 CH3-3-CH3-0-H--CH2-CH2-0- (4-CH3-Ph) 160 CH3-3-CH3-0-H--CH2-CH2-0- (4-CH30-Ph) 161 CH3- 3-CH3-O- H- -CH2-CH2-S-Ph 162 CH3-3-CH3-O-H--CH2-CH2-NH-Ph 163 CH3-3-CH3-O-H--CH2-CH2-O-CH3 164 CH3-3-CH3-O-H--CH2-CH2-O-CH2-CH3 165 CH3-3-CH3-O-H--CH2-CH2-O-CH2-CH=CH2 166 CH3- 3-CH3-O- H- -CH2-CH2-O-CH2-C#CH 167 (CH3) 2N- 3-CH3-O- H- -H 168 (CH3) 2N-3-CH3-O-H--CH3 169 (CH3) 2N-3-CH3-O-H--CF3 170 (CH3) 2N-3-CH3-O-H-CHF2 171 (CH3) 2N- 3-CH3-O- H- -CH2-CH3 172 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-CH3 173 (CH3) 2N-3-CH3-O-H--CH2-CH=CH2 174 (CH3) 2N- 3-CH3-O- H- -CH2-CH=CH-CH3 175 (CH3) 2N- 3-CH3-O- H- -CH2-(CH3)C=CH2 176 (CH3) 2N- 3-CH3-O- H- -CH2-CH=CHCl 177 (CH3) 2N- 3-CH3-O- H- -CH2-C#CH 178 (CH3) 2N- 3-CH3-O- H- -CH(CH3)-C#CH 179 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-CF3 180 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-CH3 181 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-CH2-CH3 182 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-(CH2)2-CH3 183 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-(CH2)4-CH3 184 (CH3) 2N- 3-CH3-0-H--CH2-C=C-C3H5-cycl 185 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-C5H9-cycl 186 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-C6H11-cycl 187 (CH3) 2N- 3-CH3-O- H- -CH2-Ph 188 (CH3) 2N- 3-CH3-O- H- -CH2-(3-Cl-Ph) 189 (CH3) 2N- 3-CH3-O-H--CH2- (4-F-Ph) 190 (CH3) 2N- 3-CH3-O- H- -CH2-(4-Cl-Ph) 191 (CH3) 2N- 3-CH3-O- H- -CH2-(4-Br-Ph) 192 (CH3) 2N- 3-CH3-O- H- -CH2-(4-I-Ph) 193 (CH3) 2N- 3-CH3-0-H--CH2- (4-CH3-Ph) 194 (CH3) 2N- 3-CH3-0-H--CH2- (3-NO2-Ph) 195 (CH3) 2N- 3-CH3-0-H--CH2- (4-CN-Ph) 196 (CH3) 2N- 3-CH3-O- H- -CH2-(4-CH3O-Ph) 197 (CH3) 2N- 3-CH3-0-H--CH2- (4-H2C=CH-Ph) 198 (CH3) 2N- 3-CH3-O- H- -CH2-(4-CH3S-Ph) 199 (CH3) 2N- 3-CH3-0-H--CH2- (4-CF3S-Ph) 200 (CH3) 2N- 3-CH3-O- H- -CH2-(3,4-Cl2-Ph) 201 (CH3) 2N- 3-CH3-0-H--CH2- (3-CF3-Ph) 202 (CH3) 2N- 3-CH3-0-H--CH2-C=C-Ph 203 (CH3) 2N- 3-CH3-O-H--CH2-C=C- (4-CH3-Ph) 204 (CH3) 2N- 3-CH3-O-H--CH2-C=C- (4-CI-Ph) 205 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-(4-F-Ph) 206 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-(4-Br-Ph) 207 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-(3-CN-Ph) 208 (CH3) 2N- 3-CH3-O- H- -CH2-C#C-(3,4-Cl-Ph) 209 (CH3) 2N-3-CH3-O-H--CH2-CH2-O-Ph 210 (CH3) 2N- 3-CH3-0-H--CH2-CH2-0- (4-F-Ph) 211 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-O-(4-Cl-Ph) 212 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-O-(4-Br-Ph) 213 (CH3) 2N- 3-CH3-0-H--CH2-CH2-0- (4-CH3-Ph) 214 (CH3) 2N- 3-CH3-0-H--CH2-CH2-0- (4-CH30-Ph) 215 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-S-Ph 216 (CH3) 2N-3-CH3-O-H--CH2-CH2-NH-Ph 217 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-O-CH3 218 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-O-CH2-CH3 219 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-O-CH2-CH=CH2 220 (CH3) 2N- 3-CH3-O- H- -CH2-CH2-O-CH2-C#CH 221 CH3-CH2-CH2-3-CH3-O-H--CH3 222 CH3-CH2-CH2-3-CH3-O-H--CH2-CH3 223 CH3-CH2-CH2-3-CH3-O-H--CH2-CH=CH2 224 CH3-CH2-CH2-3-CH3-O-H--CH2-C=CH 225 CH3-CH2-CH2-3-CH3-O-H--CH2-C_C-CH2-CH3 226 CH3-CH2-CH2- 3-CH3-O- H- CH2-C#C-C3H5-cycl 227 CH3-CH2-CH2-3-CH3-O-H--CH2-C=C-Ph 228 CH3-CH2-CH2- 3-CH3-O- H- CH2-C#C-(4-Cl-Ph) 229 CH3-CH2-CH2-3-CH3-O-H--CH2-CH2-O-Ph 230 CH3-CH2-CH2- 3-CH3-O- H- CH2-CH2-O-(4-F-Ph) 231 CH3-CH2-CH2-3-CH3-0-H--CH2-CH2-0- (4-Cl-Ph) 232 (CH3) 2CH- 3-CH3-O- H- -CH3 233 (CH3) 2CH-3-CH3-O-H--CH2-CH3 234 (CH3) 2CH- 3-CH3-O- H- -CH2-CH=CH2 235 (CH3) 2CH- 3-CH3-O- H- -CH2-C#CH 236 (CH3) 2CH- 3-CH3-O- H- -CH2-C#C-CH2-CH3 237 (CH3) 2CH- 3-CH3-O- H- -CH2-C#C-C3H5-cycl 238 (CH3) 2CH- 3-CH3-O- H- -CH2-C#C-Ph 239 (CH3) 2CH- 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 240 (CH3) 2CH- 3-CH3-O- H- -CH2-CH2-O-Ph 241 (CH3) 2CH- 3-CH3-0-H--CH2-CH2-0- (4-F-Ph) 242 (CH3) 2CH- 3-CH3-O-H--CH2-CH2-O- (4-CI-Ph) 243 CH3-(CH2) 3-3-CH3-O-H--CH3 244 CH3-(CH2)3- 3-CH3-O- H- -CH2-CH3 245 CH3-(CH2) 3-3-CH3-O-H--CH2-CH=CH2 246 CH3- (CH2) 3- 3-CH3-0-H--CH2-C=-CH 247 CH3- (CH2) 3- 3-CH3-O-H--CH2-C=C-CH2-CH3 248 CH3- (CH2) 3- 3-CH3-0-H--CH2-C=C-C3H5-cycl 249 CH3-(CH2)3- 3-CH3-O- H- -CH2-C#C-Ph 250 CH3- (CH2) 3- 3-CH3-0-H--CH2-C= 251 CH3-(CH2)3- 3-CH3-O- H- -CH2-CH2-O-Ph 252 CH3- (CH2) 3- 3-CH3-0-H--CH2-CH2-0- (4-F-Ph) 253 CH3-(CH2)3- 3-CH3-O- H- -CH2-CH2-O-(4-Cl-Ph) 254 CH2=CH-3-CH3-O-H--CH3 255 CH2=CH- 3-CH3-O- H- -CH2-CH3 256 CH2=CH-3-CH3-O-H--CH2-CH=CH2 257 CH2=CH- 3-CH3-O- H- -CH2-C#CH 258 CH2=CH- 3-CH3-O- H- -CH2-C#C-CH2-CH3 259 CH2=CH-3-CH3-O-H--CH2-C=C-C3H5-cycl 260 CH2=CH-3-CH3-O-H--CH2-C=C-Ph 261 CH2=CH- 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 262 CH2=CH-3-CH3-O-H--CH2-CH2-O-Ph 263 CH2=CH-3-CH3-0-H--CH2-CH2-0- (4-F-Ph) 264 CH2=CH- 3-CH3-O- H- -CH2-CH2-O-(4-Cl-Ph) 265 CH3-3-CH3-CH2-O-H--CH3 266 CH3-3-CH3-CH2-O-H--CH2-CH3 267 CH3-3-CH3-CH2-O-H--CH2-CH=CH2 268 CH3-3-CH3-CH2-O-H--CH2-C=CH 269 CH3- 3-CH3-CH2-O- H- -CH2-C#C-CH2-CH3 270 CH3- 3-CH3-CH2-O- H- -CH2-C#C-C3H5-cycl 271 CH3-3-CH3-CH2-0-H--CH2-C=C-Ph 272 CH3- 3-CH3-CH2-O- H- -CH2-C#C-(4-Cl-Ph) 273 CH3-3-CH3-CH2-O-H--CH2-CH2-O-Ph 274 CH3-3-CH3-CH2-0-H--CH2-CH2-0- (4-F-Ph) 275 CH3- 3-CH3-CH2-O- H- -CH2-CH2-O-(4-Cl-Ph) 276 (CH3) 2N- 3-CH3-CH2-O- H- -CH3 277 (CH3) 2N-3-CH3-CH2-O-H--CH2-CH3 278 (CH3) 2N- 3-CH3-CH2-O- H- -CH2-CH=CH2 279 (CH3) 2N- 3-CH3-CH2-O- H- -CH2-C#CH 280 (CH3) 2N- 3-CH3-CH2-O- H- -CH2-C#C-CH2-CH3 281 (CH3) 2N- 3-CH3-CH2-O- H- -CH2-C#C-C3H5-cycl 282 (CH3) 2N-3-CH3-CH2-O-H--CH2-C_C-Ph 283 (CH3) 2N- 3-CH3-CH2-O- H- -CH2-C#C-(4-Cl-Ph) 284 (CH3) 2N-3-CH3-CH2-O-H--CH2-CH2-O-Ph 285 (CH3) 2N- 3-CH3-CH2-0-H--CH2-CH2-0- (4-F-Ph) 286 (CH3) 2N- 3-CH3-CH2-O- H- -CH2-CH2-O-(4-Cl-Ph) 287 CH3- 3-CH3- H- -CH3 288 CH3-3-CH3-H--CH2-CH3 287 CH3- 3-CH3- H- -CH2-CH=CH2 290 CH3-3-CH3-H--CH2-C-CH 291 CH3- 3-CH3- H- -CH2-C#C-CH2-CH3 291 CH3- 3-CH3- H- -CH2-C#C-C3H5-cycl 293 CH3-3-CH3-H--CH2-C=C-Ph 294 CH3- 3-CH3- H- -CH2-C#C-(4-Cl-Ph) 295 CH3-3-CH3-H--CH2-CH2-O-Ph 296 CH3-3-CH3-H--CH2-CH2-0- (4-F-Ph) 297 CH3- 3-CH3- H- -CH2-CH2-O-(4-Cl-Ph) 298 (CH3) 2N- 3-CH3-H--CH3 299 (CH3) 2N- 3-CH3- H- -CH2-CH3 300 (CH3) 2N- 3-CH3- H- -CH2-CH=CH2 301 (CH3) 2N- 3-CH3-H--CH2-C=CH 302 (CH3) 2N- 3-CH3-H--CH2-C=C-CH2-CH3 303 (CH3) 2N- 3-CH3-H--CH2-C=C-C3H5-cycl 304 (CH3) 2N- 3-CH3- H- -CH2-C#C-Ph 305 (CH3) 2N- 3-CH3-H--CH2-C=C- (4-CI-Ph) 306 (CH3) 2N- 3-CH3- H- -CH2-CH2-O-Ph 307 (CH3) 2N- 3-CH3- H- -CH2-CH2-O-(4-F-Ph) 308 (CH3) 2N- 3-CH3- H- -CH2-CH2-O-(4-Cl-Ph) 309 CH3- 3-Cl- H- -CH3 310 CH3- 3-Cl- H- -CH2-CH3 311 CH3- 3-Cl- H- -CH2-CH=CH2 312 CH3- 3-Cl- H- -CH2-C#CH 313 CH3- 3-Cl- H- -CH2-C#C-CH2-CH3 314 CH3- 3-Cl- H- -CH2-C#C-C3H5-cycl 315 CH3-3-CI-H--CH2-C_C-Ph 316 CH3- 3-Cl- H- -CH2-C#C-(4-Cl-Ph) 317 CH3-3-Cl-H--CH2-CH2-0-Ph 318 CH3-3-CI-H--CH2-CH2-O-(4-F-Ph) 319 CH3-3-CI-H--CH2-CH2-O- (4-CI-Ph) 320 (CH3) 2N- 3-Cl-H--CH3 321 (CH3) 2N- 3-Cl- H- -CH2-CH3 322 (CH3) 2N- 3-Cl- H- -CH2-CH=CH2 323 (CH3) 2N- 3-Cl- H- -CH2-C#CH 324 (CH3) 2N-3-CI-H--CH2-C-C-CH2-CH3 325 (CH3) 2N- 3-Cl- H- -CH2-C#C-C3H5-cycl 326 (CH3)2N- 3-Cl- H- -CH2-C#C-Ph 327 (CH3) 2N-3-CI-H--CH2-C-C-(4-CI-Ph) 328 (CH3)2N- 3-Cl- H- -CH2-CH2-O-Ph 329 (CH3) 2N- 3-Cl- H- -CH2-CH2-O-(4-F-Ph) 330 (CH3) 2N- 3-CI-H--CH2-CH2-O- (4-CI-Ph) 331 CH3- 3-CH3-O- 5-CH3-O- CH3 332 CH3- 3-CH3-O- 5-CH3-O- CH2-CH3 333 CH3- 3-CH3-O- 5-CH3-O- CH2-CH-CH2 334 CH3-3-CH3-O-5-CH3-O--CH2-C=CH 335 CH3- 3-CH3-O- 5-CH3-O- -CH2-C#C-CH2-CH3 336 CH3-3-CH3-O-5-CH3-O--CH2-C--C-C3H5-cycl 337 CH3-3-CH3-O-5-CH3-O--CH2-C=C-Ph 338 CH3- 3-CH3-O- 5-CH3-O- -CH2-C#C-(4-Cl-Ph) 339 CH3-3-CH3-O-5-CH3-O--CH2-CH2-O-Ph 340 CH3- 3-CH3-O- 5-CH3-O- -CH2-CH2-O-(4-F-Ph) 341 CH3- 3-CH3-O- 5-CH3-O- -CH2-CH2-O-(4-Cl-Ph) 342 (CH3) 2N- 3-CH3-O- 5-CH3-O- -CH3 343 (CH3) 2N- 3-CH3-O- 5-CH3-O- -CH2-CH3 344 (CHs) 2N- 3-CH3-O- 5-CH3-O- -CH2-CH=CH2 345 (CH3) 2N- 3-CH3-O- 5-CH3-O- -CH2-C#CH 346 (CH3) 2N- 3-CH3-0-5-CH3-0--CH2-C=C-CH2-CH3 347 (CH3)2N- 3-CH3-O- 5-CH3-O- -CH2-C#C-C3H5-cycl 348 (CH3)2N- 3-CH3-O- 5-CH3-O- -CH2-C#C-Ph 349 (CH3) 2N- 3-CH3-O-5-CH3-O--CH2-C=C- (4-CI-Ph) 350 (CH3)2N- 3-CH3-O- 5-CH3-O- -CH2-CH2-O-Ph 351 (CH3)2N- 3-CH3-O- 5-CH3-O- -CH2-CH2-O-(4-F-Ph) 352 (CH3) 2N- 3-CH3-O-5-CH3-O--CH2-CH2-O- (4-CI-Ph) 353 (CH3)-(CH2)3- 3-CH3-O- H- -CH3 354 Cl-(CH2)3- 3-CH3-O- H- -CH3 355 -C5H9-cycl 3-CH3-O- H- -CH3 356 -C6H11-cycl 3-CH3-O-H--CH3 357 CH3-SO2-CH2-3-CH3-O-H--CH3 358 CH300C-CH2-3-CH3-O-H--CH3 359-N (CH2) 4 3-CH3-O-H--CH3 360 (CH3)-(CH2) 3-3-CH3-O-H--CH2-CH2-O-Ph 361 Cl-(CH2)3- 3-CH3-O- H- -CH2-CH2-O-Ph 362 -C5H9-cycl 3-CH3-O- H- -CH2-CH2-O-Ph 363 -C6H11-cycl 3-CH3-O- H- -CH2-CH2-O-Ph 364 CH3-SO2-CH2- 3-CH3-O- H- -CH2-CH2-O-Ph 365 CH3OOC-CH2- 3-CH3-O- H- -CH2-CH2-O-Ph 366-N (CH2)4 3-CH3-O- H- -CH2-CH2-O-Ph 367 (CH3)- (CH2) 3- 3-CH3-O-H--CH2-C=C- (4-CI-Ph) 368 Cl-(CH2)3- 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 369-C5H9-cycl 3-CH3-O-H--CH2-C=C- (4-CI-Ph) 370 -C6H11-cycl 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 371 CH3-S02-CH2-3-CH3-O-H--CH2-C=C- (4-CI-Ph) 372 CH30OC-CH2-3-CH3-0-H--CH2-C=C- (4-Cl-Ph) 373-N (CH2)4 3-CH3-O- H- -CH2-C#C-(4-Cl-Ph) 374 CH3-3-Br-H--CH3 375 CH3-3-Br-H--CH2-CH2-O-Ph 376 CH3-3-Br-H--CH2-C=C- (4-CI-Ph) 377 (CH3)2N- 3-Br- H- -CH3 378 (CH3) 2N- 3-Br- H- -CH2-CH2-O-Ph 379 (CH3) 2N-3-Br-H--CH2-C-C-(4-CI-Ph) 380 CH3-2-F-H--CH3 381 CH3-2-F-H--CH2-CH2-O-Ph 382 CH3-2-F-H--CH2-C_C-(4-CI-Ph) 383 (CH3) 2N- 2-F-H--CH3 384 (CH3) 2N- 2-F- H- -CH2-CH2-O-Ph 385 (CH3) 2N- 2-F- H- -CH2-C#C-(4-Cl-Ph) 386 CH3- 3-(CH2=CH-CH2-O)- H- -CH3 387 CH3- 3-(CH2=CH-CH2-O)- H- CH2-CH2-O-Ph 388 CH3- 3-(CH2=CH-CH2-O)- H- -CH2-C#C-(4-Cl-Ph) 389 (CH3) 2N- 3-(CH2=CH-CH2-O)- H- -CH3 390 (CH3) 2N- 3- (CH2=CH-CH2-0)- H--CH2-CH2-0-Ph 391 (CH3) 2N- 3-(CH2=CH-CH2-O)- H- -CH2-C#C-(4-Cl-Ph) 392 CH3- 3-(CH#C-CH2-O)- H- -CH3 393 CH3-3- (CH=-C-CH2-0)- H--CH2-CH2-0-Ph 394 CH3-3-(CH_C-CH2-O)-H--CH2-C-C-(4-CI-Ph) 395 (CH3) 2N- 3- (CH-=C-CH2-0)- H--CH3 396 (CH3) 2N- 3-(CH#C-CH2-O)- H- -CH2-CH2-O-Ph 397 (CH3) 2N- 3- (CH=C-CH2-O)- H--CH2-C=C- (4-CI-Ph) Formulations may be prepared analogously to those described in, for example, WO 95/30651.

Biological Examples D-1: Action against Plasmopara viticola (downy mildew) on vines 5 week old grape seedlings cv. Gutedel are treated with the formulated test compound in a spray chamber. One day after application grape plants are inoculated by spraying a sporangia suspension (4 x 104 sporangia/ml) on the lower leaf side of the test plants. After an incubation period of 6 days at +21 OC and 95% r. h. in a greenhouse the disease incidence is assessed.

Compounds of Tables 1 to 44 exhibit a good fungicidal action against Plasmopara viticola on vines. Compounds 1. 087,1. 093,1. 094,1. 095,1. 100,1. 107,1. 110,1. 117,1. 126,1. 127, 1.177, 1.202, 1. 204,1. 205,1. 210,1. 211,12. 093,12. 095,12. 123,12. 177 and 12.181 at 200 ppm inhibit fungal infestation in this test to at least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

D-2: Action against Phytophthora (late blight) on tomato plants 3 week old tomato plants cv. Roter Gnom are treated with the formulated test compound in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (2 x 104 sporangia/mi) on the test plants. After an incubation period of 4 days at +18 C and 95% r. h. in a growth chamber the disease incidence is assessed.

Compounds of Tables 1 to 44 exhibit a long-lasting effect against fungus infestation.

Compounds 1.087, 1.094, 1.095, 1.100, 1. 107, 1.110, 1.117, 1.126, 1.127, 1.202, 1.204, 1.205, 1.210, 1.211, 12.093, 12.095, 12.123, 12.127, 12. 177 and 12. 181 at 200 ppm inhibit fungal infestation in this test to at least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

D-3: Action against Phytophthora (late blight) on potato plants 5 week old potato plants cv. Bintje are treated with the formulated test compound in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (14 X 104 sporangia/ml) on the test plants. After an incubation period of 4 days at +18°C and 95% r. h. in a growth chamber the disease incidence is assessed.

Fungal infestation is effectively controlled with compounds of Tables 1 to 44.

Compounds 1.107, 1.126, 1.127, 1.202, 1.204, 1.205, 1.210, 1. 211, 12.127 and 12.181 at 200 ppm inhibit fungal infestation in this test to at least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.